Disorders of thyroid, IBD co-morbidities

THYROID_DISORDER_IBD

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints THYROTOXICOSIS THYROIDITIS DIS_THYROID_OTH	16566
6. Filter based on genotype QC (FinnGen only)	14979

Control definitions (FinnGen only)

Control exclude: IBD_COMORB

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	THYROID_DISORDER_IBD
CONTROL_EXCLUDE	IBD_COMORB
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	THYROTOXICOSIS\|THYROIDITIS\|DIS_THYROID_OTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Disorders of thyroid, IBD co-morbidities based on the number of shared cases.

Similar with more cases:

Endocrine, nutritional and metabolic diseases

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	14979	11960	3019
Unadjusted period prevalence (%)	3.67	4.25	1.38
Median age at first event (years)	52.10	50.34	59.07

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
11041: Matched controls
75544

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A10BJ06

ATC

semaglutide; parenteral

+∞

322.4

358

ZXA00

NOMESCO Finland

Right side

2.9

321.2

1887

4947

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.6

320.6

2409

7210

C10AA01

ATC

simvastatin; oral

2.5

313.7

2626

8282

A28

ICPC

Limited function/disability NOS

3.9

312.1

1097

2053

WX320

NOMESCO Finland

Spinalanesthesy

2.8

311.2

1974

5394

A02BC03

ATC

lansoprazole; oral

2.6

311.2

2325

6927

J01DB01

ATC

cefalexin; oral

2.4

310.6

8668

45231

N05CF01

ATC

zopiclone; oral

2.5

309.9

2788

9094

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

59.9

309.7

240

ZXD10

NOMESCO Finland

Scheduled procedure

2.3

307.9

3556

12968

NF1AA

NOMESCO Finland

Hip X-ray examination

10.9

307.7

537

352

H03AA01

ATC

levothyroxine sodium; systemic

14.2

307.7

6454

6803

N02AX02

ATC

tramadol; systemic, rectal

4.0

307.7

3935

9094

L28

ICPC

Limited function/disability (L)

5.0

307.7

1409

2148

C10AA05

ATC

atorvastatin; oral

2.7

307.7

3130

9698

B01AB05

ATC

enoxaparin; parenteral

2.7

307.7

2679

8136

G44.2

ICD-10 Finland

Tension-type headache

4.5

307.7

1408

2397

L13

ICPC

Hip symptom/complaint

3.4

307.7

1517

3339

T85

ICPC

Hyperthyroidism/thyrotoxicosis

87.4

307.7

477

A10AE04

ATC

insulin glargine; parenteral

67.0

307.7

800

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

2334.5

307.7

4218

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

4.4

307.7

1143

1927

N03AX16

ATC

[U] pregabalin

6.7

307.7

1957

2346

A02BC02

ATC

pantoprazole; systemic

3.4

307.7

7080

25926

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

167.8

307.7

356

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

4.1

307.7

1137

2075

M54.9

ICD-10 Finland

Dorsalgia, unspecified

4.3

307.7

1131

1935

I48

ICD-10 Finland

Atrial fibrillation and flutter

3.6

307.7

1684

3588

A10BH01

ATC

sitagliptin; oral

835.5

307.7

579

103

Kela drug reimbursment

Diabetes, insulin-treated

286.3

307.7

2019

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

7.2

307.7

2654

3176

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

4.2

307.7

3691

8092

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

33.0

307.7

701

155

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

8.1

307.7

958

878

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1108.5

307.7

603

I50.9

ICD-10 Finland

Heart failure, unspecified

4.5

307.7

986

1598

A10BK03

ATC

empagliflozin; oral

80.8

307.7

687

T90

ICPC

Diabetes non-insulin dependent

22.2

307.7

1670

601

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

77.8

307.7

395

E05.80

ICD-10 Finland

Subacute thyrotoxicosis

279.5

307.7

935

M54.5

ICD-10 Finland

Low back pain

3.5

307.7

3675

9399

215

Kela drug reimbursment

Diabetes, non-insulin-treated

433.1

307.7

1933

A10BK01

ATC

dapagliflozin; oral

56.5

307.7

557

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

7.5

307.7

603

580

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.6

307.7

4504

12074

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

57.8

307.7

446

M79.0

ICD-10 Finland

Rheumatism, unspecified

65.8

307.7

272

M54.4

ICD-10 Finland

Lumbago with sciatica

5.3

307.7

1678

2461

A10AB04

ATC

insulin lispro; parenteral

97.2

307.7

331

M01AC06

ATC

meloxicam; systemic, rectal

2.6

307.7

2944

9277

C01BD01

ATC

amiodarone; systemic

12.7

307.7

564

319

ACC51

NOMESCO Finland

Release of median nerve

350.3

307.7

582

E11

ICD-10 Finland

Type 2 diabetes mellitus

23.0

307.7

985

321

OAB50, ,

SPAT

8.1

307.7

597

528

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.9

307.7

1211

1861

C07AB07

ATC

bisoprolol; oral

5.0

307.7

5463

12394

A10BA02

ATC

metformin; oral

25.2

307.7

2021

667

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

7.9

307.7

725

665

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

176.4

307.7

252

M75.1

ICD-10 Finland

Rotator cuff syndrome

3.7

307.7

2077

4458

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.5

307.7

2707

6436

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

19.6

307.7

1181

459

M48.0

ICD-10 Finland

Spinal stenosis

44.3

307.7

732

121

R06.0

ICD-10 Finland

Dyspnoea

3.5

307.7

2627

6261

R51.80

ICD-10 Finland

Headache

3.9

307.7

1662

3277

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

3.2

307.7

1991

4802

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.2

307.7

4175

12016

N06AX11

ATC

mirtazapine; oral

2.5

307.7

3232

10849

S06.0

ICD-10 Finland

Concussion

10.1

307.7

850

620

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

22.6

307.7

377

118

L15

ICPC

Knee symptom/complaint

2.8

307.7

2096

5763

E05.89

ICD-10 Finland

Other thyrotoxicosis

+∞

307.7

471

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

28.3

307.7

735

190

T89

ICPC

Diabetes insulin dependent

103.0

307.7

434

A02BC05

ATC

esomeprazole; systemic

2.6

307.7

3831

12957

E05

ICD-10 Finland

Thyrotoxicosis [hyperthyroidism]

206.9

307.7

1260

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

29.2

307.7

868

220

H03BB01

ATC

carbimazole; oral

1515.6

307.7

6739

EP1AE

NOMESCO Finland

Neck ultrasound examination

7.6

307.7

1184

1171

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

+∞

307.7

617

A10AC01

ATC

insulin (human); parenteral

18.0

307.7

671

270

Z01.0

ICD-10 Finland

Examination of eyes and vision

3.5

307.7

1709

3771

M79.6

ICD-10 Finland

Pain in limb

3.6

307.7

4383

11752

E06.9

ICD-10 Finland

Thyroiditis, unspecified

192.3

307.7

380

R07.4

ICD-10 Finland

Chest pain, unspecified

3.0

307.7

2509

6713

Z01.8

ICD-10 Finland

Other specified special examinations

3.2

307.7

2200

5404

A10AB01

ATC

insulin (human); parenteral

141.6

307.7

341

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

6.7

307.7

634

679

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.5

307.7

3890

13554

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

12.5

307.7

945

561

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

7.5

307.7

652

631

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

230.7

307.7

545

AA1AD

NOMESCO Finland

CT of head and brain

6.1

307.7

2305

3130

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

9.4

307.7

849

663

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

5.5

307.7

817

1074

S18

ICPC

Laceration/cut

2.3

307.7

4062

15201

I10

ICD-10 Finland

Essential (primary) hypertension

2.5

307.7

4898

18012

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

8.9

307.7

559

449

L03

ICPC

Low back symptom/complaint

2.7

307.7

2829

8486

R03AC02

ATC

salbutamol; inhalant

2.3

307.7

5736

23991

M01AX05

ATC

glucosamine; oral

4.6

307.7

1045

1695

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

307.7

415

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

97.8

307.7

659

J01AA02

ATC

doxycycline; systemic

2.4

307.7

7890

38572

207

Kela drug reimbursment

Chronic arrhythmias

4.2

307.7

1306

2359

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

36.3

307.7

399

C07AA05

ATC

propranolol; systemic

5.6

307.7

3822

6533

M25.5

ICD-10 Finland

Pain in joint

4.1

307.7

3341

7231

L17

ICPC

Foot/toe symptom/complaint

2.6

307.7

2777

8526

E05.2

ICD-10 Finland

Thyrotoxicosis with toxic multinodular goitre

3294.6

307.7

1301

N02BE01

ATC

paracetamol; systemic, rectal

3.8

307.7

9462

46193

C07AB02

ATC

metoprolol; systemic

3.5

307.7

1708

3798

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

16.5

307.7

621

272

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

18.9

307.7

384

144

SPAT1262

SPAT

Handing over of treatment supplies

6.7

307.7

1343

1541

G47.3

ICD-10 Finland

Sleep apnoea

13.8

307.7

1951

1157

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

9.3

307.7

546

419

M13.9

ICD-10 Finland

Arthritis, unspecified

9.9

307.7

547

396

T86

ICPC

Hypothyroidism/myxoedema

6.7

307.7

1039

1145

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

4.2

307.7

1798

3367

R42

ICD-10 Finland

Dizziness and giddiness

3.0

307.7

2006

5144

C08CA01

ATC

amlodipine; oral

2.5

307.7

2783

8907

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

27.7

307.7

451

116

P01BA02

ATC

hydroxychloroquine; oral

22.4

307.7

614

198

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

11413.4

307.7

4817

R5140

NOMESCO Finland

Monitoring the use of the aid

13.4

307.7

792

434

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.6

307.7

4409

15381

ZXE10

NOMESCO Finland

More than one and less than three hours

2.7

307.7

3348

10608

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

42.7

307.7

1214

218

E03.2

ICD-10 Finland

Hypothyroidism due to medicaments and other exogenous substances

105.3

307.7

314

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

294.2

307.7

908

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

17.0

307.7

780

336

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

6.1

307.7

787

942

C03CA01

ATC

furosemide; systemic

3.9

307.7

2237

4623

Z3226

NOMESCO Finland

Physiotherapist

3.4

307.7

1521

3360

N06AX21

ATC

duloxetine; oral

5.7

307.7

1103

1449

M01AB05

ATC

diclofenac; systemic, rectal

2.3

307.7

6367

28087

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

181.2

307.7

334

E06.3

ICD-10 Finland

Autoimmune thyroiditis

61.2

307.7

641

E03

ICD-10 Finland

Other hypothyroidism

5.3

307.7

1149

1615

M01AH01

ATC

celecoxib; oral

3.9

307.7

1283

2475

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

121.5

307.7

277

A10AE05

ATC

insulin detemir; parenteral

275.5

307.7

463

M16.1

ICD-10 Finland

Other primary coxarthrosis

24.5

307.7

668

198

TPH04

NOMESCO Finland

Cathetrisation of vein

2.9

307.7

2075

5511

A10BB12

ATC

glimepiride; oral

114.8

307.7

294

BAA60

NOMESCO Finland

Total thyroidectomy

35.6

307.7

1630

366

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

98.3

307.7

239

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

4.1

307.7

1262

2297

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

3.4

307.7

2281

5381

M79.7

ICD-10 Finland

Fibromyalgia

18.5

307.7

336

128

M17.1

ICD-10 Finland

Other primary gonarthrosis

13.9

307.7

1436

804

N06AA09

ATC

amitriptyline; systemic

6.5

307.7

658

734

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

307.7

383

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

49.6

307.7

876

131

G56.0

ICD-10 Finland

Carpal tunnel syndrome

11.9

307.7

1194

765

E06.1

ICD-10 Finland

Subacute thyroiditis

+∞

307.7

976

R53

ICD-10 Finland

Malaise and fatigue

2.8

307.7

2785

8155

A10AB05

ATC

insulin aspart; parenteral

57.2

307.7

683

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

81.4

307.7

522

M19.0

ICD-10 Finland

Primary arthrosis of other joints

13.5

307.7

677

363

N02BF01

ATC

gabapentin; oral

10.0

307.7

854

629

N03AX12

ATC

[U] gabapentin; oral

13.0

307.7

1358

809

104

Kela drug reimbursment

Thyroid insufficiency

17.1

307.7

2352

1177

M03BX02

ATC

tizanidine; oral

2.5

307.7

6304

26416

A07EC01

ATC

sulfasalazine; oral, rectal

12.4

307.7

530

305

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

44.1

307.7

1675

305

H02AB06

ATC

prednisolone; systemic

3.6

307.7

5257

15135

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

16.3

307.7

715

319

M01AH05

ATC

etoricoxib; oral

2.7

307.7

6084

23664

E03.89

ICD-10 Finland

Other specified hypothyroidism

10.8

307.7

980

673

M03BC01

ATC

orphenadrine (citrate); systemic

2.9

307.7

2089

5597

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

44.9

307.7

447

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

12.4

307.7

930

556

M70.6

ICD-10 Finland

Trochanteric bursitis

5.1

307.7

1077

1556

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

569.0

307.7

478

L04AX03

ATC

methotrexate; systemic

10.2

307.7

712

506

N02AJ06

ATC

codeine and paracetamol; systemic

3.1

307.7

4115

12060

R4110

NOMESCO Finland

Physiotherapy

2.6

305.9

2359

7135

M01AE03

ATC

ketoprofen; systemic, rectal

2.4

302.6

3057

10500

M01AE02

ATC

naproxen; oral, rectal

2.1

302.4

5529

24223

L88

ICPC

Rheumatoid/seropositive arthritis

41.3

300.9

248

B01AA03

ATC

warfarin; systemic

3.4

300.6

1355

3015

B01AF01

ATC

rivaroxaban; oral

4.6

300.1

847

1327

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

3.1

298.8

1590

3923

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

3.0

295.1

1594

3966

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

590.3

293.1

335

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

5.6

292.3

667

857

XCK10

NOMESCO Finland

Photography of fundus of eye

5.3

292.3

713

978

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

30.9

291.3

256

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

14.9

290.7

330

156

A02BC01

ATC

omeprazole; systemic

2.5

290.5

2419

7577

N02BF02

ATC

pregabalin; oral

6.9

290.4

541

557

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

15.2

289.5

325

150

M02AA07

ATC

piroxicam; topical

2.4

288.9

2787

9348

M79.1

ICD-10 Finland

Myalgia

3.1

288.0

1454

3471

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

8.6

286.4

451

374

N80.1

ICD-10 Finland

Endometriosis of ovary

55.6

284.7

223

NE1AA

NOMESCO Finland

Pelvis X-ray examination

8.0

284.6

470

416

B01AF02

ATC

apixaban; oral

3.9

281.9

1007

1903

A10AE06

ATC

insulin degludec; parenteral

2161.2

280.1

314

Z3231

NOMESCO Finland

Registered nurse

2.5

280.1

2450

7840

J45.9

ICD-10 Finland

Asthma, unspecified

2.8

278.9

1723

4619

M03BC51

ATC

orphenadrine, combinations; systemic

2.4

278.4

2527

8225

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

11.8

278.1

356

213

UJF32

NOMESCO Finland

Coloscopy

2.6

278.0

2135

6413

L90

ICPC

Osteoarthrosis of knee

9.3

274.2

406

308

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.6

273.6

2083

6226

C10AX09

ATC

ezetimibe; oral

3.4

271.8

1213

2674

A01

ICPC

Pain general/multiple sites

4.3

271.5

846

1437

A06AC01

ATC

ispaghula (psylla seeds); oral

2.5

271.4

2233

6930

WX408

NOMESCO Finland

General anesthesy, balanced

2.4

269.2

2388

7676

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

5.3

268.6

649

881

B01AC04

ATC

clopidogrel; oral

4.0

267.7

906

1642

M54.3

ICD-10 Finland

Sciatica

7.5

266.3

465

442

XF400

NOMESCO Finland

ECG with 12 standard connections

3.2

265.9

1267

2911

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

59.5

264.2

205

TFP20

NOMESCO Finland

Cardiodefibrillation

4.7

263.4

724

1106

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

102.8

262.6

192

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.1

262.5

1333

3184

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.7

262.3

1771

4969

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

10.6

262.3

358

239

M20.1

ICD-10 Finland

Hallux valgus (acquired)

6.9

261.7

486

498

L08

ICPC

Shoulder symptom/complaint

2.6

259.3

1945

5756

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.3

258.8

2700

9314

A10BJ02

ATC

liraglutide; parenteral

68.6

258.6

197

J01FF01

ATC

clindamycin; systemic

2.4

258.0

2425

7987

C10AA07

ATC

rosuvastatin; oral

2.3

258.0

2718

9414

205

Kela drug reimbursment

Chronic hypertension

2.8

256.7

1617

4368

SPAT1153

SPAT

Removal of sutures

2.4

255.4

2394

7870

M01AX17

ATC

nimesulide; oral

2.8

255.1

1642

4487

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

18.6

255.0

263

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

4.7

253.8

692

1049

R4120

NOMESCO Finland

Occupational therapy

6.9

251.6

471

487

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

3.5

250.5

1048

2209

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

4.5

250.4

732

1178

H02AB07

ATC

prednisone; oral

3.1

248.7

1250

2963

E07.9

ICD-10 Finland

Disorder of thyroid, unspecified

36.4

247.2

209

R4110, ,

SPAT

3.5

246.6

1043

2214

G43.9

ICD-10 Finland

Migraine, unspecified

5.1

245.6

621

879

ZXA05

NOMESCO Finland

Left side

2.7

245.6

1703

4833

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

+∞

245.5

273

WX780

NOMESCO Finland

Remote monitoring CPAP

654.6

245.4

280

R60.0

ICD-10 Finland

Localized oedema

3.6

244.3

982

2013

N05BA04

ATC

oxazepam; oral

2.3

243.9

2427

8174

WX723

NOMESCO Finland

CPAP therapy

284.7

243.2

285

E66.01

ICD-10 Finland

Obesity due to excess calories

3.8

241.9

898

1740

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.9

241.6

861

1619

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

247.0

239.9

283

C03DA01

ATC

spironolactone; oral

3.5

239.6

1001

2106

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

955.6

239.2

271

R5110, ,

SPAT

5.3

238.4

572

770

A10AA02, ,

ATC

245.2

238.1

281

H04AA01

ATC

glucagon; nasal, parenteral

244.3

237.2

280

WX110

NOMESCO Finland

Infiltration anesthesia

2.0

235.9

7543

39002

C09AA05

ATC

ramipril; oral

2.6

234.9

1687

4866

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.8

233.3

1485

4021

M54.1

ICD-10 Finland

Radiculopathy

12.0

232.3

294

172

J01DA01

ATC

[U] cefalexin

1.9

232.1

6066

29181

ZXA10

NOMESCO Finland

Bilateral

2.7

232.0

1577

4420

R00.2

ICD-10 Finland

Palpitations

3.4

229.4

1008

2191

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

5.9

227.9

487

583

L01BA01

ATC

methotrexate; systemic

27.6

227.7

206

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

4.2

227.3

715

1220

R02

ICPC

Shortness of breath/dyspnoea

3.1

227.1

1162

2778

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.6

226.6

1712

5058

SPAT1263

SPAT

Sampling

2.0

226.3

3870

16054

SPAT1216

SPAT

Assessment of functional ability

3.4

224.1

975

2104

M43.1

ICD-10 Finland

Spondylolisthesis

21.9

223.5

217

A10AA01, ,

ATC

301.3

221.5

259

A10BH05

ATC

linagliptin; oral

878.2

221.2

251

P01AB01

ATC

metronidazole; oral, rectal

2.0

220.7

3926

16482

WX402

NOMESCO Finland

General anaesthesia

2.2

220.4

2375

8235

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.9

220.2

1234

3109

N04BC05

ATC

pramipexole; oral

6.0

219.1

464

550

A11CC03

ATC

alfacalcidol; systemic

10.9

218.4

292

188

N03AF02

ATC

oxcarbazepine; oral

28.4

218.4

196

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.5

217.4

1656

4905

M47.9

ICD-10 Finland

Spondylosis, unspecified

38.1

216.2

181

XF404

NOMESCO Finland

Ambulatory ECG

4.0

216.2

741

1351

ZXE00

NOMESCO Finland

One hour or less

2.0

216.1

3760

15636

N80.0

ICD-10 Finland

Endometriosis of uterus

27.7

215.7

195

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

+∞

215.7

240

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

92.0

215.3

159

J01FA06

ATC

roxithromycin; oral

2.0

215.0

3622

14887

J02AC01

ATC

fluconazole; systemic

1.9

214.7

4235

18380

N06AX16

ATC

venlafaxine; oral

2.8

214.7

1313

3471

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

3.9

214.5

755

1404

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.1

214.1

2709

10008

M54.2

ICD-10 Finland

Cervicalgia

4.3

213.9

660

1108

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

4.5

212.3

617

986

M01AH02

ATC

rofecoxib; oral

3.8

211.9

775

1482

N05AH04

ATC

quetiapine; oral

2.5

211.3

1603

4734

M47.82

ICD-10 Finland

Other spondylosis, cervical region

14.9

211.2

239

112

SPAT1229

SPAT

Assessment of need for aid

6.1

209.9

433

499

SPAT1097

SPAT

Recording of ECG

3.1

209.3

1077

2578

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

36.0

207.7

176

E05.1

ICD-10 Finland

Thyrotoxicosis with toxic single thyroid nodule

+∞

207.5

231

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

5.1

206.5

512

710

WX722

NOMESCO Finland

PEEP

11.8

206.2

263

156

J01MA02

ATC

ciprofloxacin; systemic

2.0

206.1

3300

13280

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

7.0

206.0

378

381

Z71.8

ICD-10 Finland

Other specified counselling

2.0

205.2

3575

14816

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.7

204.0

1301

3513

R01AD09

ATC

mometasone; nasal

1.9

203.2

4636

21007

E66.8

ICD-10 Finland

Other obesity

5.1

202.2

499

689

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

7.3

201.7

355

340

H04.10

ICD-10 Finland

Dry eye syndrome

2.8

201.6

1260

3365

XA800

NOMESCO Finland

Neuropsychological investigation

9.5

201.4

293

216

A04

ICPC

Weakness/tiredness general

2.5

201.2

1571

4697

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

200.8

3854

16482

H53.2

ICD-10 Finland

Diplopia

7.8

200.6

335

300

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.8

200.1

5564

26805

N06AB04

ATC

citalopram; systemic

2.4

200.0

1771

5615

X59

ICD-10 Finland

Exposure to unspecified factor

2.5

199.6

1529

4529

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.9

199.0

1099

2739

WX002

NOMESCO Finland

Sedation and analgesia

2.6

198.9

1410

4019

R52.2

ICD-10 Finland

Other chronic pain

8.7

197.7

306

247

C09CA06

ATC

candesartan; oral

2.3

197.6

2027

6850

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

197.4

1891

6205

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

44.4

196.9

160

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

4.8

196.9

525

778

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

61.6

195.5

151

A02BA02

ATC

ranitidine; systemic

2.6

195.2

1412

4063

R52.9

ICD-10 Finland

Pain, unspecified

3.2

194.7

926

2110

L86

ICPC

Back syndrome with radiating pain

5.4

194.7

455

596

E66.00

ICD-10 Finland

Metabolic syndrome

6.4

194.2

387

429

SPAT1249

SPAT

Treatment-related counselling outside office

1.9

193.6

3740

15985

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

+∞

193.1

215

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

33.5

190.4

164

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

19.4

189.3

192

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

4.1

188.3

603

1041

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.0

188.2

1024

2527

M54.6

ICD-10 Finland

Pain in thoracic spine

3.8

188.2

670

1254

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

5.5

188.2

429

548

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.7

187.6

1177

3144

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.6

186.6

715

1411

R20.2

ICD-10 Finland

Paraesthesia of skin

3.8

186.2

663

1241

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

28.8

185.7

166

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

5.8

184.4

403

493

R50.9

ICD-10 Finland

Fever, unspecified

2.5

184.3

1434

4269

M22.4

ICD-10 Finland

Chondromalacia patellae

12.1

184.0

231

133

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

50.6

183.7

146

C07AA07

ATC

sotalol; systemic

6.3

183.3

370

416

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.7

183.0

1206

3304

N02AA05

ATC

oxycodone; systemic

2.7

182.9

1181

3201

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

17.0

182.5

195

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.8

182.0

5163

24771

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.0

181.9

2950

11833

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.6

181.0

1255

3528

L89

ICPC

Osteoarthrosis of hip

16.0

180.9

198

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

7.9

180.9

299

264

C08CA13

ATC

lercanidipine; oral

3.0

180.2

927

2212

M04AA01

ATC

allopurinol; systemic

3.6

180.0

708

1422

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

4.8

179.7

478

706

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

10.6

179.3

243

160

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

21.3

178.7

175

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.1

178.6

873

2020

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.9

178.1

3100

12725

C09AA02

ATC

enalapril; systemic

2.6

177.7

1253

3551

R05

ICPC

Cough

2.1

177.1

2353

8773

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.5

177.0

716

1466

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

83.1

176.9

132

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

+∞

176.9

197

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

66.8

176.6

135

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

19.8

176.2

177

H02AB04

ATC

methylprednisolone; systemic

2.7

175.8

1156

3160

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

16.2

175.4

191

SPAT1301

SPAT

No procedures

2.0

175.2

2582

9994

E10

ICD-10 Finland

Type 1 diabetes mellitus

352.8

174.6

203

M01AB55

ATC

diclofenac, combinations; oral

5.4

174.3

407

532

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.8

174.3

3936

17549

C09CA01

ATC

losartan; oral

2.2

174.2

1790

6024

L12

ICPC

Hand/finger symptom/complaint

2.4

173.5

1509

4723

K80

ICPC

Cardiac arrhythmia NOS

3.2

173.5

831

1898

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

46.2

173.5

140

K78

ICPC

Atrial fibrillation/flutter

4.2

173.1

548

937

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

6.2

173.0

352

399

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.3

172.9

1706

5643

A10BD07

ATC

metformin and sitagliptin; systemic

1310.7

172.8

195

M23.8

ICD-10 Finland

Other internal derangements of knee

8.0

172.7

283

247

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.2

172.5

1921

6680

TAB00

NOMESCO Finland

Lumbar puncture

7.3

172.3

305

294

J01FA10

ATC

azithromycin; systemic

1.8

171.6

5907

29808

XF402

NOMESCO Finland

ECG with work load test

3.4

171.3

738

1575

A10BB01

ATC

glibenclamide; oral

87.9

171.2

127

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.8

171.1

4562

21359

N80.9

ICD-10 Finland

Endometriosis, unspecified

21.5

170.9

167

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

19.4

170.7

173

N05BA01

ATC

diazepam; systemic, rectal

2.9

170.6

965

2430

SPAT1310

SPAT

Counselling related to known health issue

2.0

170.6

2688

10638

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

11.4

170.3

221

135

M65.3

ICD-10 Finland

Trigger finger

6.6

170.2

325

343

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

232.1

169.8

201

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

4.0

169.6

572

1027

M10.9

ICD-10 Finland

Gout, unspecified

5.8

169.3

367

445

R13

ICD-10 Finland

Dysphagia

3.9

169.3

581

1057

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

3.5

168.6

690

1423

J01FA09

ATC

clarithromycin; systemic

1.9

167.6

2890

11784

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.9

167.6

2704

10780

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.0

166.7

2663

10576

CL2S4, ,

SPAT

78.6

166.6

125

P20

ICPC

Memory disturbance

3.5

166.4

680

1401

R11

ICD-10 Finland

Nausea and vomiting

3.1

166.4

815

1886

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.2

165.9

792

1804

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

8.9

164.8

250

196

R03DC03

ATC

montelukast; oral

2.3

164.2

1531

4934

E89.09

ICD-10 Finland

Postprocedural hypothyroidism, other or several procedures

52.5

163.2

129

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

18.1

162.3

169

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

3.2

161.3

766

1738

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

76.1

160.7

121

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

+∞

160.7

179

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.5

160.4

1178

3398

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

3.0

160.2

841

2027

L01

ICPC

Neck symptom/complaint

2.3

160.1

1490

4794

R00.0

ICD-10 Finland

Tachycardia, unspecified

4.1

160.0

521

910

N39.4

ICD-10 Finland

Other specified urinary incontinence

3.5

159.5

639

1298

R06.5

ICD-10 Finland

Mouth breathing

3.5

159.3

653

1347

WZC00

NOMESCO Finland

Treatment plan or consultation

1.8

158.9

3519

15495

250, ,

Kela drug reimbursment

31.9

158.4

138

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

7.9

158.1

263

234

M09AX01

ATC

hyaluronic acid; parenteral

10.7

157.9

213

139

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

1284.2

157.6

178

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

30.1

157.3

139

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

217.1

156.5

186

G04BD12

ATC

mirabegron; oral

3.1

156.4

765

1767

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

156.2

7522

41276

C03AA03

ATC

hydrochlorothiazide; oral

3.9

156.0

535

972

C01DA14

ATC

isosorbide mononitrate; oral

3.0

155.9

820

1978

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

29.9

155.8

138

R01BA52

ATC

pseudoephedrine, combinations; oral

1.9

155.8

2641

10667

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

16.4

155.3

168

A29

ICPC

General symptom/complaint other

2.5

154.9

1139

3285

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

183.2

153.3

184

P06

ICPC

Sleep disturbance

2.5

153.1

1174

3454

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.9

152.9

845

2096

J01MA12

ATC

levofloxacin; systemic

2.3

152.9

1407

4500

UDQ12

NOMESCO Finland

Flexible laryngoscopy

4.0

152.6

513

918

R06AE07

ATC

cetirizine; oral

1.7

152.5

4353

20589

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.4

151.9

1282

3944

R07.3

ICD-10 Finland

Other chest pain

2.9

151.2

831

2055

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

3.9

150.7

510

917

J01CA04

ATC

amoxicillin; systemic

1.9

150.5

8556

49022

N03AX11

ATC

topiramate; oral

10.7

150.3

202

131

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

40.8

150.2

124

NHK30

NOMESCO Finland

Osteotomy or rotation osteotomy of first metatarsal or tarsal bone

243.4

149.1

176

R01AD08

ATC

fluticasone; nasal

1.9

149.0

2785

11587

H06.2

ICD-10 Finland

Dysthyroid exophthalmos

+∞

148.9

166

WZC30

NOMESCO Finland

Teaching

2.3

148.9

1373

4392

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.3

148.8

1344

4260

I50.0

ICD-10 Finland

Congestive heart failure

4.3

148.7

443

720

NDM20

NOMESCO Finland

Excision of synovial ganglion of wrist or hand

51.0

148.6

118

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

1194.7

147.7

167

N03AF01

ATC

carbamazepine; oral, rectal

6.5

147.6

287

309

M20.2

ICD-10 Finland

Hallux rigidus

20.9

147.2

145

C01AA05

ATC

digoxin; systemic

3.7

147.1

554

1077

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

5.1

147.0

364

503

JN3AD

NOMESCO Finland

Abdominal CT examination

2.6

146.6

1034

2918

A08

ICPC

Swelling

4.4

146.3

433

700

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

24.3

146.1

137

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

29.8

145.6

129

G40.9

ICD-10 Finland

Epilepsy, unspecified

237.7

145.5

172

N05CF02

ATC

zolpidem; oral

2.2

145.1

1509

5075

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

4.7

144.0

387

576

R25.1

ICD-10 Finland

Tremor, unspecified

7.4

143.5

250

236

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.6

143.5

1008

2838

N03AG01

ATC

valproic acid; systemic, rectal

4.4

143.1

421

677

NA1AD

NOMESCO Finland

Cervical spine CT examination

5.8

143.1

307

368

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

2.1

143.0

1789

6467

N03AE01

ATC

clonazepam; systemic

5.2

142.7

348

474

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

10.6

142.4

193

127

G54.0

ICD-10 Finland

Brachial plexus disorders

9.7

142.3

203

145

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

7.6

142.1

241

220

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

13.8

140.9

165

G56.2

ICD-10 Finland

Lesion of ulnar nerve

10.0

139.9

196

136

SPAT1260

SPAT

Consultation of another employee

2.2

139.9

1375

4512

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.6

139.9

990

2796

SPAT1254

SPAT

Administration of medicine

2.5

139.7

1036

2994

M05BA04

ATC

alendronic acid; oral

3.9

139.5

482

880

M50.3

ICD-10 Finland

Other cervical disc degeneration

19.8

139.3

140

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.2

139.0

1391

4599

XA402

NOMESCO Finland

ENMG

16.2

138.1

150

R05FB02

ATC

cough suppressants and expectorants; systemic

1.8

137.7

2961

12814

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

137.6

5649

29196

177

Kela drug reimbursment

Insulin glargine 300 U / ml

+∞

137.2

153

C01BC04

ATC

flecainide; systemic

5.2

137.0

330

444

UKC02

NOMESCO Finland

Cystoscopy

2.4

136.3

1079

3215

D01

ICPC

Abdominal pain/cramps general

2.3

135.6

1218

3843

AN1

Coronary angiography

3.2

135.3

613

1348

I50.1

ICD-10 Finland

Left ventricular failure

4.9

134.9

349

502

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3026008) Bacteria identified in Urine by Culture

3360

11806

2.36

318.77

3.2

2.2

—

(3002032) Base excess in Venous blood by calculation

1238

2500

3.69

317.58

4.2

2.9

1.74

mmol/l

0.03

1097

2176

(3012544) pH of Venous blood

1272

2621

3.62

317.05

4.2

3.0

7.38

2.05

707

1399

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1705

4282

3.04

311.83

3.1

2.2

30.07

29.77

0.92

1660

4170

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1452

3314

3.30

310.21

1.9

1.5

—

(3032080) INR in Blood by Coagulation assay

4943

14729

3.35

307.65

17.6

9.1

1.26

1.19

inr

16.02

4197

12059

(3023368) Bacteria identified in Blood by Culture

2976

8928

2.75

307.65

4.7

3.5

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1626

1803

7.06

307.65

3.4

3.0

65.58

76.94

ng/l

5.21

1453

1592

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3682

3977

9.00

307.65

1.4

1.2

198.12

156.88

u/ml

4.56

1743

1554

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

9672

52768

3.05

307.65

5.2

3.1

5.87

5.42

mmol/l

187.78

9067

49270

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3298

7578

3.82

307.65

4.5

2.4

1157.74

973.82

ng/l

2.11

2848

6444

(3023420) DNA double strand Ab [Units/volume] in Serum

690

760

6.56

307.65

2.0

1.3

7.27

5.32

iu/ml

0.49

152

108

(3019309) Folate [Moles/volume] in Red Blood Cells

1822

4289

3.28

307.65

1.8

1.6

1101.56

1131.15

nmol/l

0.66

1461

3203

(3021589) Normoblasts [#/volume] in Blood

5465

21438

2.47

307.65

12.7

7.2

0.00

e9/l

0.21

4493

17201

(3044889) 12 lead EKG panel

7704

32920

2.99

307.65

4.5

2.6

0.50

8248.47

—

(3013115) Eosinophils [#/volume] in Blood

6591

22458

3.50

307.65

6.8

4.6

0.19

0.18

e9/l

0.57

5872

19386

(40758558) Short blood count panel - Blood

3964

13396

2.60

307.65

7.1

5.8

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3591

7008

4.71

307.65

2.3

1.6

181.70

182.79

u/l

0.02

3429

6582

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

5890

2314

36.19

307.65

6.8

2.7

4.84

4.50

pmol/l

37.09

5589

2091

(3019198) Lymphocytes [#/volume] in Blood

6503

22259

3.43

307.65

6.6

4.4

1.91

1.94

e9/l

0.83

5832

19432

(3001122) Ferritin [Mass/volume] in Serum or Plasma

6321

28280

2.24

307.65

3.9

2.7

98.29

89.54

ug/l

2.99

5960

27014

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

10549

51057

10.28

307.65

15.5

3.8

1.69

1.84

mu/l

14.09

10264

47695

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

6706

17419

5.16

307.65

8.3

5.1

1.21

mmol/l

0.86

5887

14879

(3013512) EKG study

3624

11519

2.72

307.65

3.9

2.5

0.86

0.75

—

(3022948) Iron [Moles/volume] in Serum or Plasma

2321

5768

3.22

307.65

2.9

1.9

13.80

14.70

umol/l

5.23

2171

5419

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6063

21886

2.99

307.65

6.6

6.8

10.67

11.87

umol/l

11.32

5790

20816

(3035350) Ketones [Presence] in Urine by Test strip

5931

25410

2.29

307.65

4.2

2.5

7.29

1.42

estimate

1.42

1312

4858

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4296

12185

3.31

307.65

4.1

2.2

61.15

59.84

ng/l

0.02

2651

6209

(3022096) Basophils/Leukocytes in Blood

5918

19850

3.24

307.65

6.8

4.6

0.67

0.68

0.87

5552

18531

(3007164) IgA [Mass/volume] in Serum or Plasma

3074

9705

2.62

307.65

1.6

1.3

2.19

2.17

g/l

0.33

1918

6398

(3018095) Leukocytes [#/volume] in Urine

4258

16077

2.32

307.65

4.4

2.8

69.23

94.51

e6/l

1.80

3038

9750

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5988

15258

4.68

307.65

7.5

4.8

1.21

mmol/l

1.24

5656

14055

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2299

6202

2.94

307.65

4.6

2.7

442.32

838.80

ng/l

0.92

1639

4237

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

10396

41825

12.99

307.65

14.0

3.4

15.54

14.31

pmol/l

307.65

10144

38700

(3013826) Glucose [Moles/volume] in Serum or Plasma

6695

23271

3.46

307.65

5.8

3.6

6.60

6.04

mmol/l

82.22

6343

20854

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2356

6819

2.73

307.65

1.7

1.4

26347741.64

26967304.23

pmol/l

0.02

2004

5885

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

8811

34772

4.63

307.65

9.7

6.6

77.75

77.89

u/l

0.10

8518

32720

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1994

4685

3.33

307.65

2.9

1.9

23.02

24.72

5.19

1849

4378

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1274

2571

3.70

307.65

4.1

2.9

5.86

5.78

kpa

2.00

1236

2503

(3026493) Urate [Moles/volume] in Serum or Plasma

2956

8682

2.82

307.65

2.7

2.0

328.57

320.99

umol/l

3.30

2598

7978

(3019069) Monocytes/Leukocytes in Blood

5938

19885

3.26

307.65

6.8

4.6

8.67

8.61

0.80

5576

18654

(3030467) Casts [#/volume] in Urine by Automated count

3222

10812

2.47

307.65

3.5

2.4

0.35

0.49

e6/l

2.07

2398

6993

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2253

5540

3.24

307.65

4.0

3.7

0.82

0.83

mmol/l

5.17

2144

5284

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

10261

54898

4.95

307.65

18.6

8.0

20.36

25.98

mg/l

56.51

8774

40013

(3002582) Erythrocytes [#/volume] in Urine

3685

12595

2.50

307.65

3.7

2.4

72.05

108.28

e6/l

0.88

2863

8671

(3024561) Albumin [Mass/volume] in Serum or Plasma

5108

16809

3.01

307.65

5.1

4.6

36.13

36.36

g/l

1.92

4811

15784

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5901

20317

3.12

307.65

2.8

2.0

75.20

75.26

nmol/l

0.05

5488

18945

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2638

5477

4.02

307.65

1.4

1.1

24.04

14.49

iu/ml

5.97

791

1447

(3019550) Sodium [Moles/volume] in Serum or Plasma

10302

54166

5.50

307.65

21.3

8.8

139.70

139.75

mmol/l

1.52

10177

52361

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

8692

32851

4.81

307.65

5.0

2.3

10.98

9.43

mm/h

23.05

8309

30396

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4879

15991

2.95

307.65

2.2

1.6

96.45

96.74

pmol/l

0.15

2760

8553

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1787

3642

3.81

307.65

5.8

4.7

1.05

1.02

mmol/l

3.23

1677

3363

(3006315) Basophils [#/volume] in Blood

6401

21466

3.48

307.65

6.6

4.4

0.04

e9/l

0.04

5605

18253

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1969

4864

3.15

307.65

2.0

1.6

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

9497

49774

3.18

307.65

6.8

2.9

39.16

35.64

mmol/mol

236.72

9020

46768

(3002030) Lymphocytes/Leukocytes in Blood

6070

20954

3.18

307.65

6.7

4.4

28.45

29.11

4.46

5751

19877

(3018418) pH of Serum or Plasma

4466

9798

4.56

307.65

4.9

3.4

7.40

0.75

3254

6456

(3018010) Neutrophils/Leukocytes in Blood

5939

20442

3.14

307.65

6.6

4.4

56.78

56.49

1.00

5690

19557

(3015377) Calcium [Moles/volume] in Serum or Plasma

4666

13890

3.25

307.65

3.2

4.2

2.34

2.35

mmol/l

10.55

4303

12818

(3000850) Epithelial cells [#/volume] in Urine

2574

7726

2.67

307.65

2.9

2.0

6.23

6.69

e6/l

0.62

2365

6770

(3015736) pH of Urine

4826

19637

2.21

307.65

3.6

2.4

6.21

6.22

0.19

2723

11031

(3031040) Bacteria [#/volume] in Urine by Automated count

7122

33183

2.32

307.65

5.1

3.1

2274.89

1099.70

e6/l

0.58

111

370

(3020682) Albumin/Creatinine [Ratio] in Urine

3373

7092

4.25

307.65

4.8

2.0

7.73

8.79

mg/mmol

0.58

2118

3611

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2192

5248

3.32

307.65

2.8

1.8

2.39

g/l

0.04

2025

4873

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3400

10056

2.90

307.65

2.6

1.9

2.67

2.62

mg/l

0.53

2970

8566

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4086

15114

2.35

307.65

3.4

3.0

30.27

32.64

u/l

0.85

3906

14481

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3019

8054

3.15

307.65

2.6

1.5

0.91

1.37

mg/l

12.39

2292

6081

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1757

2846

4.83

307.65

2.4

2.7

376.22

404.02

nmol/l

5.49

1637

2667

(3021601) Nitrite [Presence] in Urine by Test strip

5882

25099

2.29

307.65

4.1

2.5

0.00

estimate

0.02

1282

4856

(3023103) Potassium [Moles/volume] in Serum or Plasma

10318

54362

5.56

307.65

21.5

8.9

3.95

3.92

mmol/l

6.06

10175

52398

(3037467) Urinalysis macro (dipstick) panel - Urine

7421

33957

2.51

307.65

5.0

3.0

2.81

2.35

—

(3037522) Nuclear Ab [Titer] in Serum

2154

3897

4.46

307.65

1.5

1.2

533.28

412.36

titre

1.79

509

602

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

5125

700

92.62

307.65

2.7

1.3

19.55

2.09

iu/l

1.42

2682

219

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3545

11460

2.64

307.65

1.5

1.2

1.62

1.99

u/ml

0.89

1002

3354

(3009261) Glucose [Presence] in Urine by Test strip

5948

25743

2.26

307.65

4.2

2.6

0.05

0.00

estimate

0.62

1234

4853

(3001604) Monocytes [#/volume] in Blood

6385

21439

3.46

307.65

6.6

4.4

0.56

0.55

e9/l

5.19

5593

18227

(3009508) Creatinine [Moles/volume] in Urine

3698

9235

3.62

307.65

3.8

1.8

7.54

8.34

mmol/l

14.70

3168

8049

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3795

12157

2.73

307.65

2.8

2.3

64.20

68.86

u/l

0.26

3535

11289

(3021960) Folate [Moles/volume] in Serum or Plasma

3132

9427

2.78

307.65

1.8

1.4

19.63

20.17

nmol/l

1.28

2752

8138

(3012516) Albumin [Mass/volume] in Urine

3329

6931

4.27

307.65

4.0

1.8

51.78

54.08

mg/l

0.10

2168

3572

(3006504) Eosinophils/Leukocytes in Blood

5916

19856

3.24

307.65

6.7

4.5

2.83

0.09

5554

18602

(3013650) Neutrophils [#/volume] in Blood by Automated count

7502

25779

4.09

307.65

10.2

8.6

3.91

3.94

e9/l

0.48

6552

21924

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2425

4634

4.31

307.65

1.4

1.1

6.08

1.44

u/ml

6.61

978

1948

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

9846

52860

3.54

307.65

17.6

8.2

85.83

87.42

ml/min/173m2

11.14

9249

46460

(3020630) Protein [Mass/volume] in Serum or Plasma

1024

1763

4.28

307.65

2.3

3.0

65.88

65.82

g/l

0.08

948

1642

(3004588) Protein electrophoresis panel - Serum or Plasma

782

1117

5.08

307.36

2.1

2.6

—

(36304419) Bacteria [Presence] in Urine

3067

10534

2.37

303.79

3.4

2.4

0.00

0.07

estimate

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

10555

61609

4.91

298.68

23.4

9.9

73.86

72.03

umol/l

8.09

10479

60594

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2344

7253

2.54

288.43

2.9

3.4

2.43

mmol/l

0.22

2057

6512

(3026782) Osmolality of Urine

2259

6882

2.57

286.78

3.0

2.2

517.49

544.01

mosm/kgh2o

5.82

1997

5864

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

10558

62021

4.77

283.69

15.1

7.0

25.10

24.68

u/l

1.45

10407

60004

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1374

3198

3.22

283.29

1.9

1.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5391

23838

2.07

280.54

3.0

2.4

—

estimate

—

(3033658) Prothrombin time (PT) actual/Normal

3020

10616

2.30

280.30

4.8

3.4

90.15

92.57

5.35

2950

10403

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

727

1085

4.84

271.69

3.6

3.2

5.12

5.07

kpa

0.62

694

1028

(3005719) IgG [Mass/volume] in Serum or Plasma

1060

2134

3.65

271.54

2.7

2.5

10.31

10.82

g/l

2.99

978

1976

(3015171) Extractable nuclear Ab [Units/volume] in Serum

625

816

5.50

269.21

1.3

1.1

0.63

0.55

u/ml

0.07

(40768797) Stomach Pathology biopsy report

1744

4801

2.76

268.14

1.3

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

309

156

13.91

263.72

1.4

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

1034

2107

3.60

259.97

3.7

2.5

4.58

4.60

kpa

0.11

994

2043

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1122

2419

3.42

259.59

4.0

3.1

1.22

1.23

mmol/l

2.25

986

2022

(3014576) Chloride [Moles/volume] in Serum or Plasma

1581

4197

2.84

259.29

9.2

6.5

104.50

104.88

mmol/l

2.25

1581

4197

(3009343) pH of Capillary blood

697

1061

4.73

254.45

3.6

3.2

7.42

0.76

566

882

(3017732) Neutrophils [#/volume] in Blood

1638

4483

2.76

253.62

2.9

2.8

4.31

4.19

e9/l

0.33

1441

3962

(3000475) Leukocytes [#/volume] in Synovial fluid

276

121

15.98

251.39

1.8

1.2

9143.59

14189.19

e6/l

0.30

193

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

516

600

6.12

248.38

1.9

1.2

0.23

0.24

g/l

0.86

491

566

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

525

623

6.00

247.96

1.9

1.2

1.20

1.16

g/l

1.93

498

593

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1292

3138

3.06

246.77

9.4

7.0

5.06

5.08

kpa

0.31

1244

3016

(3027801) Oxygen [Partial pressure] in Arterial blood

1291

3136

3.06

246.51

9.4

7.0

12.48

14.18

kpa

17.00

1244

3015

(3027945) Reticulocytes/Erythrocytes in Blood

1344

3368

2.97

243.22

2.6

2.4

1.74

1.64

2.33

1212

3017

(3019977) pH of Arterial blood

1285

3149

3.03

241.52

9.5

7.0

7.42

0.58

651

1462

(3003396) Base excess in Arterial blood by calculation

1275

3135

3.02

238.12

9.4

7.0

0.88

0.58

mmol/l

1.67

1045

2578

(3016502) Oxygen saturation in Arterial blood

1160

2722

3.14

234.03

9.9

7.5

95.27

96.42

5.34

1118

2625

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1011

2175

3.40

233.82

2.4

2.3

16.77

20.85

au/ml

1.13

125

414

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

541

709

5.44

231.72

1.3

1.1

42.66

8.87

u/ml

1.70

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

260

123

14.79

228.77

2.5

2.0

61.66

97.74

ug/min

0.34

167

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

250

111

15.74

226.37

1.7

1.3

16.95

13.15

pmol/l

4.40

226

(3020779) Urea [Moles/volume] in Serum or Plasma

1075

2459

3.21

225.70

10.4

5.2

9.52

7.98

mmol/l

8.88

1029

2368

(3042936) Bacteria identified in Isolate by Culture

1600

4607

2.61

222.75

2.3

1.6

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

589

875

4.81

220.55

1.4

1.2

12.11

7.52

iu/ml

0.33

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

927

1955

3.45

220.51

4.1

2.4

240.85

193.24

ng/l

1.04

851

1788

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

930

1975

3.43

218.88

1.3

1.2

40.19

50.21

au/ml

0.67

209

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3015

11604

2.07

214.15

2.5

2.0

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

675

1154

4.20

213.87

2.4

2.3

38.56

41.79

u/l

2.97

604

1067

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

491

634

5.50

213.30

1.3

1.1

19.97

5.88

u/ml

1.26

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4412

19476

1.92

211.95

4.0

2.4

1.08

0.16

estimate

0.74

1063

3957

(3025159) Blasts/Leukocytes in Blood

1089

2613

3.05

210.88

4.3

3.9

0.05

0.70

2.00

266

633

(3017181) Myelocytes/Leukocytes in Blood

1104

2671

3.03

210.82

4.2

3.7

1.03

1.06

0.07

308

758

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

601

946

4.54

210.46

3.5

3.2

1.69

1.73

mmol/l

0.07

436

679

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

9923

58123

2.66

209.41

5.9

3.7

2.74

2.93

mmol/l

85.00

9401

54964

(3029937) Albumin [Presence] in Urine by Test strip

3189

12627

2.02

208.87

4.3

2.5

0.00

estimate

2.12

1220

4511

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2014

6644

2.31

208.76

3.2

2.3

1.01

1.22

e6/l

0.91

1092

3001

(3028026) IgM [Mass/volume] in Serum or Plasma

857

1777

3.49

208.73

1.8

2.0

1.23

1.47

g/l

1.98

798

1646

(3014111) Lactate [Moles/volume] in Serum or Plasma

1111

2715

3.00

208.49

10.1

6.6

1.29

1.26

mmol/l

0.32

1089

2663

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

486

637

5.41

207.90

1.3

1.1

11.81

2.16

u/ml

0.87

(3000991) Gas panel - Venous blood

1097

2676

3.00

206.41

11.2

7.4

—

(3019225) pH of Specimen

1169

2971

2.89

204.75

4.5

2.9

7.37

7.35

1.43

915

1992

(3002179) Metamyelocytes/Leukocytes in Blood

1049

2514

3.05

203.27

4.0

3.7

0.73

0.76

0.16

301

735

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

535

785

4.85

202.92

1.3

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

9344

53521

2.27

201.21

4.4

3.0

1.25

1.14

mmol/l

48.10

8785

50477

(3021440) Promyelocytes/Leukocytes in Blood

1056

2557

3.02

201.01

4.3

3.8

0.08

0.12

0.51

262

656

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

9833

57620

2.53

200.06

5.3

3.5

4.63

4.88

mmol/l

115.07

9361

54759

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

7509

39839

1.91

198.37

3.6

2.4

42.53

35.19

u/l

13.43

7185

38032

(3023520) Reticulocytes [#/volume] in Blood

990

2328

3.10

197.81

2.4

2.6

71.42

66.79

e9/l

2.71

710

1640

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

787

1600

3.55

197.02

4.4

3.1

24.24

24.33

mmol/l

0.30

779

1584

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1075

2666

2.95

196.22

10.6

7.6

122.88

120.08

g/l

3.57

1048

2593

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

9789

57369

2.48

195.87

5.2

3.4

1.46

1.55

mmol/l

77.83

9271

54332

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

333

308

7.60

194.47

1.5

1.2

540.67

436.05

mg/l

1.90

318

291

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

406

475

6.03

193.93

1.2

1.1

1.29

9.11

u/ml

0.47

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1398

4033

2.57

192.12

5.6

4.9

231.13

249.57

u/l

3.32

1326

3887

(3004119) Hemoglobin [Mass/volume] in Venous blood

762

1549

3.54

190.65

3.6

2.5

132.93

130.24

g/l

2.11

742

1515

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

852

1872

3.29

189.59

2.5

1.8

9.87

11.50

ug/l

0.56

745

1669

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

312

275

7.96

189.05

1.6

1.3

532.84

156.04

e6/l

1.59

247

199

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

405

486

5.88

188.84

4.0

6.4

112.14

82.82

u/ml

0.34

158

185

(3007853) Bacteria identified in Skin by Aerobe culture

1407

4108

2.54

188.50

1.9

1.4

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

309

274

7.91

186.37

1.5

1.3

68.35

11.41

e6/l

0.85

228

187

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

492

729

4.79

184.39

2.1

2.3

7.44

7.01

g/l

4.30

459

667

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

491

729

4.78

183.59

2.1

2.3

4.21

4.14

g/l

0.89

458

667

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

489

728

4.76

182.27

2.1

2.3

3.66

3.78

g/l

0.57

456

666

(3048689) Calprotectin [Mass/mass] in Stool

1865

6281

2.24

181.90

2.2

2.7

115.25

115.81

ug/g

0.02

1459

4998

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

875

2013

3.14

180.73

1.7

1.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2690

10484

2.00

179.67

4.0

2.5

0.35

0.12

0.70

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

446

620

5.09

179.20

2.9

2.1

376.78

368.71

ug/l

0.03

414

591

(3044941) Cell count panel - Synovial fluid

198

15.48

178.21

1.6

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

300

274

7.67

176.86

1.4

1.2

3.78

3.45

mmol/l

4.79

290

258

(3008898) HLA-B27 [Presence]

541

900

4.27

176.85

1.1

1.0

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1878

6432

2.20

175.32

3.4

2.3

3.34

2.80

e6/l

1.15

951

2776

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

468

697

4.75

174.30

2.2

2.88

2.92

g/l

0.31

435

634

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

440

631

4.93

170.87

2.2

2.5

0.37

1.18

g/l

3.29

385

544

(3015235) Bicarbonate [Moles/volume] in Capillary blood

407

548

5.24

169.07

3.1

2.6

24.88

24.74

mmol/l

0.23

399

532

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

8859

50753

1.98

167.61

24.5

10.5

13.54

13.35

37.94

8768

49780

(3044290) Cell count panel - Cerebral spinal fluid

282

257

7.68

166.50

1.5

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

4503

21197

1.77

163.69

2.1

1.6

1.33

1.23

mmol/l

10.37

3798

18607

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

416

592

4.96

162.86

1.3

1.1

40.48

39.89

u/ml

0.02

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

641

1288

3.55

162.61

1.2

—

(36660697) Celiac disease serology panel - Serum

1277

3807

2.46

162.49

1.2

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

737

1634

3.24

161.07

1.7

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

429

638

4.75

159.92

2.2

2.3

9.72

10.41

g/l

1.96

393

573

(3014051) Protein [Presence] in Urine by Test strip

3367

14616

1.83

159.35

3.1

2.2

0.10

0.04

0.34

245

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

221

153

10.06

158.05

2.3

2.0

0.87

0.78

nmol/l

0.72

184

142

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1134

3237

2.56

157.62

3.3

2.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1501

4895

2.27

156.09

2.6

2.7

7.01

9.70

umol/l

4.82

1286

4346

(40768804) Tissue Pathology biopsy report

4736

22878

1.73

154.54

2.1

2.0

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

390

555

4.95

152.62

2.1

2.4

0.01

0.05

g/l

0.81

352

500

(3007461) Platelets [#/volume] in Blood

10703

67132

3.97

151.43

31.1

12.5

260.27

255.80

e9/l

10.89

10599

65242

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

378

529

5.03

150.62

2.1

2.4

0.00

g/l

0.06

334

468

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

386

553

4.91

149.93

2.7

4.0

63.01

38.69

mg/l

0.38

329

492

(3035941) MCH [Entitic mass]

10704

67187

3.95

149.91

31.0

12.5

30.09

30.16

4.50

10653

66310

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

10704

67200

3.94

149.47

31.8

12.7

40.51

41.60

3.92

10649

66260

(3034860) Kappa light chains.free [Mass/volume] in Serum

386

555

4.89

149.34

2.7

4.0

42.00

48.63

mg/l

0.60

330

494

(3024731) MCV [Entitic mean volume] in Red Blood Cells

10703

67199

3.93

149.15

31.0

12.5

90.50

90.34

3.16

10651

66322

(3026361) Erythrocytes [#/volume] in Blood

10704

67210

3.94

149.13

31.1

12.5

4.52

e12/l

0.04

10570

65118

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

733

1699

3.09

148.83

12.6

8.9

24.45

24.22

mmol/l

1.06

723

1663

(3010813) Leukocytes [#/volume] in Blood

10704

67229

3.93

148.49

31.2

12.6

6.67

6.49

e9/l

12.77

10573

65102

(3000963) Hemoglobin [Mass/volume] in Blood

10705

67252

3.93

148.06

31.3

12.6

135.22

135.77

g/l

4.23

10654

66376

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

389

570

4.80

147.36

3.7

3.6

24.72

24.73

mmol/l

0.01

364

527

(3006571) Granulocytes/Leukocytes in Synovial fluid

129

29.76

145.55

1.6

1.1

55.72

63.31

0.35

(3045414) Leukocytes [Presence] in Urine

1092

3179

2.50

145.27

2.1

1.7

0.00

0.07

estimate

4.24

219

781

(3030981) Hyaline casts [#/volume] in Urine by Automated count

936

2548

2.65

142.36

2.7

1.9

0.33

0.36

e6/l

0.23

880

2426

(3027273) Bicarbonate [Moles/volume] in Venous blood

518

983

3.73

142.22

3.3

2.4

25.43

25.26

mmol/l

0.46

502

946

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

545

1073

3.60

142.09

4.5

2.8

47.93

45.89

0.92

537

1054

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

446

759

4.15

141.41

2.5

2.2

11.76

10.64

mg/l

2.12

422

730

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

354

498

4.99

140.21

2.1

2.4

0.00

g/l

-0.00

334

468

(3027456) Digoxin [Moles/volume] in Serum or Plasma

277

304

6.37

140.07

3.6

3.1

0.85

0.80

nmol/l

0.75

218

236

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

349

494

4.96

137.30

2.6

3.9

1.40

4.59

ratio

1.20

200

285

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

407

660

4.34

136.95

1.4

1.3

9.27

3.00

iu/ml

—

(3019060) Gas panel - Arterial blood

607

1317

3.28

136.82

4.1

4.4

—

(3019150) Specific gravity of Urine by Refractometry

2541

10564

1.84

134.14

4.3

2.4

1.02

1.34

kg/l

0.80

1749

6332

(3041096) Erythrocytes [Presence] in Urine by Automated

3318

14942

1.74

134.00

3.5

2.2

0.43

0.10

estimate

0.68

1054

3808

(3010838) Calcium [Moles/time] in 24 hour Urine

353

520

4.77

132.86

2.1

2.0

5.10

5.87

mmol/24h

3.11

320

475

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

807

2107

2.75

132.60

1.2

1.1

2.97

8.47

u/ml

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

221

201

7.66

130.62

1.1

175.03

12.89

iu/ml

1.99

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

576

1246

3.28

130.35

1.9

1.8

1.49

1.38

g/l

1.47

491

1069

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

436

780

3.94

129.52

1.6

1.5

0.04

0.09

iu/ml

0.45

147

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1256

4092

2.24

129.44

2.6

2.3

42.56

45.15

u/l

0.21

1065

3556

(3005322) IgE [Units/volume] in Serum or Plasma

990

2931

2.44

126.41

1.4

1.2

154.35

256.67

u/ml

4.08

940

2746

(3004616) Nuclear Ab [Presence] in Serum

227

6.96

124.34

1.3

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

617

1441

3.04

123.26

6.1

5.7

24.26

24.46

mmol/l

0.62

584

1363

(3001019) Free T4 and TSH panel - Serum or Plasma

1242

4114

2.20

122.64

2.3

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1109

3513

2.29

121.69

2.3

0.22

g/l

0.39

1049

3330

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

264

321

5.74

121.34

1.6

1.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

684

1718

2.84

120.38

12.0

8.6

16.20

16.11

0.28

657

1647

(3020891) Body temperature

481

1038

3.27

109.03

4.7

3.4

36.95

36.87

°c

3.86

475

1031

(3000494) Fungus identified in Specimen by Culture

1417

5155

2.01

108.99

1.5

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

251

326

5.37

108.04

5.3

8.5

42.56

16.92

ug/l

1.34

175

228

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

136

11.91

107.76

1.0

1.1

8.16

0.54

nmol/l

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

399

766

3.66

107.53

1.4

1.3

281.93

279.27

ug/g

0.07

231

425

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

867

2618

2.37

105.41

1.5

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

415

840

3.47

103.62

4.8

3.3

0.38

0.33

iu/ml

1.17

233

415

(3003329) Lymphocytes/Leukocytes in Synovial fluid

22.04

102.35

1.5

1.1

35.61

30.59

0.27

(3024928) Oxygen saturation in Venous blood

369

706

3.67

99.89

3.7

2.4

62.45

0.00

355

692

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

205

236

6.04

99.21

1.2

38.29

28.57

nmol/l

—

(3016018) Differential panel - Cerebral spinal fluid

173

166

7.23

98.02

1.6

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

213

259

5.72

97.88

1.3

1.1

44.03

27.65

u/ml

—

(3035637) Corticotropin [Mass/volume] in Plasma

285

457

4.35

97.08

1.7

1.6

39.42

39.64

ng/l

0.01

285

457

(3022145) Colonoscopy Study observation

1346

5002

1.96

96.75

1.4

—

(3003129) Base excess in Capillary blood by calculation

155

135

7.95

94.68

2.0

0.51

0.75

mmol/l

0.20

143

122

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

105

15.42

94.61

1.5

1.0

6.04

4.96

u/l

0.82

(40760888) Immunoglobulin light chains.free panel - Serum

247

358

4.81

94.59

2.8

3.9

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

141

108

9.04

94.38

1.7

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

235

327

5.00

94.10

1.3

1.1

498.00

155.24

titre

0.95

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

626

1711

2.59

93.47

1.6

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

405

875

3.25

91.51

3.2

2.7

2.57

2.39

index

0.09

214

465

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

179

194

6.40

91.51

1.2

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

421

939

3.15

90.41

2.2

1.8

1.94

2.36

ug/l

0.19

371

854

(3028626) Oxygen [Partial pressure] in Capillary blood

289

501

4.03

89.31

3.6

3.0

8.34

8.56

kpa

1.08

280

487

(4146454) Self-monitoring of blood glucose

15.72

89.08

3.3

1.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

293

520

3.93

87.81

1.6

0.81

0.76

g/l

0.27

230

408

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

332

649

3.58

87.13

1.3

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

459

1124

2.87

84.11

4.3

4.2

1.64

1.65

0.07

433

1045

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

243

388

4.36

83.20

1.2

1.3

0.56

0.59

nmol/l

0.66

235

375

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1042

3720

2.01

83.18

7.2

4.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

931

3192

2.09

82.82

1.3

1.2

—

(3023410) Appearance of Cerebral spinal fluid

151

6.92

82.73

1.7

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

241

384

4.37

82.72

1.2

1.3

0.16

0.14

nmol/l

—

(3021901) Oxygen saturation in Capillary blood

229

351

4.54

82.30

3.1

2.3

90.64

90.37

0.23

221

341

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

382

852

3.14

82.00

1.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

119

9.24

80.95

1.5

1.1

2.23

1.95

mmol/l

0.90

113

(1616796) Gas panel - Central venous blood

264

464

3.96

80.13

3.3

2.7

—

(3045424) Erythrocytes [Presence] in Urine

551

1529

2.54

79.62

2.1

1.8

0.03

0.13

estimate

0.66

176

620

(3024139) IgG subclass 3 [Mass/volume] in Serum

194

265

5.08

79.25

1.4

1.3

0.32

0.40

g/l

2.31

148

186

(3006184) Hemoglobin [Mass/volume] in Capillary blood

314

632

3.47

78.97

1.9

131.07

130.49

g/l

0.13

212

514

(3028192) IgG subclass 2 [Mass/volume] in Serum

194

266

5.06

78.94

1.4

1.3

2.97

3.26

g/l

1.17

148

187

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

160

181

6.12

78.72

1.2

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

423

1030

2.88

78.25

1.3

1.4

1114.17

1151.67

titre

0.04

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

213

321

4.61

78.07

1.2

1.3

—

nmol/l

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

113

9.40

77.80

1.2

1.1

38.27

29.28

mg/l

0.89

(40759836) Histone Ab [Presence] in Serum by Immunoblot

157

177

6.14

77.49

1.2

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

193

268

5.00

77.48

1.4

1.3

6.45

6.68

g/l

0.44

145

189

(3007566) Smooth muscle Ab [Titer] in Serum

427

1052

2.85

77.36

1.3

1.4

120.23

115.10

titre

0.05

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

12.71

77.23

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

104

10.40

76.35

1.1

1.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1620

6839

1.73

76.17

1.7

1.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

12.57

75.99

1.5

1.0

94130.73

56664.90

e6/l

0.26

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

123

106

8.02

75.75

1.1

1.0

—

(3020961) Endomysium IgA Ab [Titer] in Serum

767

2527

2.16

75.30

1.2

1.1

130.19

175.44

titre

0.56

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

338

737

3.21

75.21

1.4

—

(4062490) Immunoglobulin typing, IgG

189

266

4.93

74.78

1.5

1.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

414

1026

2.83

74.20

4.6

4.4

0.87

0.89

0.43

391

949

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

208

321

4.50

74.17

1.2

1.3

0.20

0.18

nmol/l

0.26

155

259

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

153

178

5.95

73.36

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

150

171

6.07

73.29

1.2

1.1

—

(3037756) Immunofixation for Serum or Plasma

219

357

4.26

73.13

1.7

1.8

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

152

177

5.94

72.82

1.2

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

344

778

3.09

72.15

1.5

1.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

106

9.14

71.69

1.1

240.89

209.91

mg/l

0.74

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

316

684

3.22

71.13

6.0

4.0

241.71

537.09

iu/ml

1.49

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

429

1116

2.70

70.28

1.2

1.1

3.81

3.85

0.03

259

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2746

13451

1.53

69.92

1.8

1.6

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

830

2912

2.03

69.02

2.9

2.2

68.33

76.55

ml/min/173m2

6.73

381

1058

(3018405) Lactate [Moles/volume] in Arterial blood

312

685

3.18

68.66

3.7

3.3

1.35

1.42

mmol/l

0.47

307

674

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

352

832

2.96

68.55

2.5

—

(40761536) Microorganisms panel - Urine sediment

1022

3869

1.89

68.28

4.0

2.5

—

(3036489) Thrombin time

519

1512

2.42

67.62

3.2

1.8

20.89

20.73

0.19

468

1313

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

145

174

5.76

67.54

1.2

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

9.59

67.05

1.1

1.0

—

(3011985) Renin [Units/volume] in Plasma

233

429

3.77

66.49

2.1

1.8

77.45

56.42

mu/l

0.85

204

392

(3018333) Ribosomal P Ab [Presence] in Serum

141

171

5.70

65.02

1.2

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1192

4821

1.78

64.26

4.8

3.3

33.08

32.68

0.60

887

3146

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

12.49

63.56

1.1

1.0

1.15

1.28

u/l

0.15

(3023183) Ammonium ion [Moles/volume] in Plasma

251

503

3.47

63.54

2.6

31.28

38.74

umol/l

3.53

221

469

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1131

4526

1.79

63.12

1.5

—

(3012501) Base excess in Blood by calculation

251

509

3.43

62.44

3.4

2.8

2.27

2.58

mmol/l

0.91

167

309

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

465

1339

2.44

62.06

2.0

1.8

—

(3044927) Protein electrophoresis panel - Urine

110

107

7.09

61.70

1.3

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

326

788

2.89

61.05

1.8

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

9.76

60.07

1.2

1.0

—

(3022621) pH of Urine by Test strip

954

3682

1.85

59.71

2.8

1.9

6.09

6.21

3.33

648

2251

(3025941) Bacteria identified in Stool by Culture

708

2478

2.02

59.02

1.3

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

230

458

3.49

58.78

2.3

1.9

16.87

16.64

0.44

225

450

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

11.05

58.66

1.2

1.0

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

14.91

57.75

1.4

0.54

0.56

ug/l

0.04

(3003181) Sodium [Moles/volume] in Urine

207

388

3.70

57.67

1.4

1.3

65.08

61.07

mmol/l

0.54

167

288

(3000330) Specific gravity of Urine by Test strip

556

1797

2.18

56.95

3.3

2.5

1.02

ratio

0.06

495

1574

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

177

298

4.11

56.83

7.8

5.9

11.61

11.14

mg/l

0.62

167

283

(4027681) Cerebrospinal fluid IgG ratio and IgG index

9.41

56.63

1.2

0.63

0.51

ratio

0.63

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

419

1208

2.43

55.75

2.0

1.7

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

179

312

3.97

54.99

1.2

72.26

71.57

u/l

0.02

158

276

(3004775) Volume in Urine collected for unspecified duration

10.12

54.26

2.3

1.7

642.13

775.71

1.22

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

236

505

3.25

54.12

1.3

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

281

669

2.92

54.05

1.4

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

274

643

2.96

54.03

1.4

1.2

4.77

2.02

u/ml

1.52

133

217

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

235

503

3.24

53.87

2.7

2.5

1422.25

1076.38

u/ml

0.11

(3008037) Lactate [Moles/volume] in Venous blood

254

573

3.08

53.52

3.4

2.2

1.61

1.41

mmol/l

1.54

242

556

(4024509) Urine culture

520

1678

2.18

53.43

1.9

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

259

592

3.04

53.39

1.4

1.2

5.30

3.76

u/ml

1.20

128

274

(3047181) Lactate [Moles/volume] in Blood

318

820

2.70

52.93

4.6

4.8

1.33

1.28

mmol/l

0.30

281

721

(3023323) Follitropin [Units/volume] in Serum or Plasma

1108

4630

1.71

52.74

1.4

1.3

27.91

26.46

iu/l

0.70

942

3959

(40768443) Skin Pathology biopsy report

573

1941

2.08

52.03

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

8.17

51.99

1.2

1.4

134.52

130.38

nmol/l

0.20

(3002256) Pathology report gross observation

1586

7334

1.56

50.25

1.3

—

(3037121) Protein [Mass/volume] in Urine

393

1156

2.38

50.05

3.1

3.8

1216.46

284.62

mg/l

0.98

191

602

(3009466) Valproate [Moles/volume] in Serum or Plasma

172

317

3.76

49.09

5.4

7.2

372.50

399.61

umol/l

1.40

142

274

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

9.18

48.94

1.4

1.2

47.63

86.60

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

246

575

2.97

48.86

1.7

1.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

250

594

2.92

48.27

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

250

594

2.92

48.27

1.3

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

8.63

48.25

1.8

1.4

—

(3028271) Lactate [Moles/volume] in Capillary blood

179

349

3.55

47.23

1.7

1.5

1.54

1.76

mmol/l

2.22

172

341

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

194

400

3.36

47.14

1.3

1.5

339.13

391.89

pmol/l

0.73

164

352

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

242

580

2.90

46.04

1.3

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

212

471

3.12

45.84

1.5

—

(3020876) Protein [Mass/time] in 24 hour Urine

128

198

4.46

45.63

2.3

1.20

0.95

g/24h

0.48

111

(3035933) Granulocytes/Leukocytes in Blood

291

777

2.60

45.31

2.7

3.0

58.70

58.02

0.36

291

777

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

254

634

2.78

44.94

1.5

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

12.03

44.78

2.5

1.1

130.44

7.57

ug/min

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

146

260

3.88

43.68

1.1

1.2

157.14

237.30

titre

0.45

(44790049) Parainfluenza type 3 nucleic acid detection

189

403

3.25

43.64

1.5

1.3

—

(44806118) Parainfluenza type 4 nucleic acid detection

189

403

3.25

43.64

1.5

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

494

1690

2.05

43.63

1.5

1.6

0.25

0.27

mg/l

0.28

184

717

(44790047) Parainfluenza type 1 nucleic acid detection

189

404

3.24

43.47

1.5

1.3

—

(44790048) Parainfluenza type 2 nucleic acid detection

189

404

3.24

43.47

1.5

1.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

127

5.37

43.29

1.7

3.61

3.85

nmol/l

0.03

103

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

24.97

42.93

2.8

2.5

31.92

26.80

umol/l

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

361

1098

2.29

42.65

3.0

2.9

1.57

1.18

mg/l

13.87

335

1027

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

144

260

3.83

42.31

2.3

2.7

18.94

20.71

nmol/l

1.05

137

245

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

118

182

4.47

42.24

4.2

3.0

719.36

1096.87

u/ml

0.74

113

182

(21494890) Protein electrophoresis panel - 24 hour Urine

109

157

4.79

42.18

1.6

2.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

441

1466

2.10

41.99

1.1

3.62

6.04

eliau/ml

0.99

270

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

241

608

2.75

41.84

1.2

1.1

112.03

112.76

0.12

225

534

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

181

386

3.25

41.80

1.3

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

147

274

3.71

41.37

6.2

2.2

7.63

5.92

mmol/l

5.28

126

215

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

122

197

4.27

41.35

2.0

1.7

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

8505

53502

1.38

40.83

25.7

10.5

331.84

332.83

g/l

20.36

8464

53092

(3024263) Appearance of Synovial fluid

9.17

40.80

2.5

1.2

—

(3049717) Cytology report of Urine Cyto stain

377

1191

2.21

40.75

2.5

2.9

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

431

1438

2.09

40.65

3.6

2.1

94.21

90.22

2.97

415

1379

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1401

6582

1.52

40.64

1.7

1.5

1.40

1.30

5.40

1243

6004

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

144

268

3.71

40.62

1.4

1.7

—

(3011412) CD3 cells [#/volume] in Blood

137

247

3.83

40.35

2.3

2.1

1205.92

1198.40

e6/l

0.03

118

210

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

171

360

3.29

40.30

1.3

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

414

1365

2.12

40.25

4.2

2.0

181.48

182.73

0.10

398

1296

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

172

365

3.26

40.04

1.3

1.4

—

(3038515) Glucose [Moles/volume] in Venous blood

201

475

2.93

39.24

3.8

2.3

7.61

6.34

mmol/l

5.91

193

463

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

8.82

39.09

1.1

819.71

118.27

ng/l

0.53

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

158

324

3.37

38.78

1.5

1.4

—

(4195642) Thrombophilia screening test

234

606

2.68

38.70

1.3

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

168

361

3.22

38.37

1.3

1.4

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

154

314

3.39

38.13

1.5

1.4

12.27

11.20

umol/l

0.82

148

294

(3048929) Epstein Barr virus Ab [Presence] in Serum

524

1920

1.91

38.10

1.3

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

745

3060

1.71

37.29

1.1

1.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

358

1149

2.17

37.24

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

359

1158

2.16

36.89

1.2

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

108

174

4.28

36.75

1.2

1.1

78.47

75.02

u/l

0.17

100

157

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

107

173

4.26

36.25

1.2

1.1

19.67

14.13

u/l

0.61

155

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

355

1149

2.15

36.17

1.2

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

188

450

2.89

35.93

1.3

24.00

39.06

u/l

0.81

176

397

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

494

1811

1.91

35.85

1.6

1.7

9.51

13.40

u/ml

1.40

104

599

(3016750) Collection duration of Urine

8.16

35.79

2.1

1.8

504.72

509.75

min

0.10

(3005988) Vibrio sp identified in Specimen by Organism specific culture

160

349

3.17

35.72

1.3

1.4

—

(3004809) Band form neutrophils/Leukocytes in Blood

190

460

2.86

35.59

3.2

3.4

0.92

2.06

5.41

173

412

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

399

1360

2.05

35.57

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

159

348

3.16

35.31

1.3

1.4

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

187

451

2.87

35.27

1.2

1.1

91.85

92.43

0.10

182

413

(1175426) CD3 cells/Lymphocytes in Blood

116

205

3.90

35.13

2.0

1.6

73.14

71.01

0.66

108

200

(3004451) EKG impression Narrative

5.91

35.12

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

149

314

3.28

35.12

2.3

1.6

19.84

32.25

mg/l

1.98

120

(3025468) Yersinia sp identified in Specimen by Organism specific culture

158

348

3.14

34.74

1.3

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

236

652

2.51

34.39

1.2

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

159

354

3.10

34.36

1.5

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

129

251

3.55

34.25

1.4

1.7

—

(3017704) Immunofixation for Urine

6.08

34.12

1.7

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

9.70

33.88

1.1

1.0

—

(3023419) Bacteria identified in Sputum by Culture

137

280

3.38

33.84

2.5

2.4

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

115

208

3.81

33.79

2.1

1.4

141.58

131.33

0.59

108

198

(3039000) Anion gap in Blood by calculation

209

551

2.63

33.45

5.5

6.0

11.76

11.06

mmol/l

1.56

187

487

(3018572) Chloride [Moles/volume] in Blood

209

551

2.63

33.45

5.5

6.0

104.96

104.97

mmol/l

0.01

187

487

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

419

1489

1.96

33.29

4.0

2.1

3.55

3.60

g/l

0.27

399

1422

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

307

977

2.18

32.63

1.5

1.3

—

(4268621) Lupus anticoagulant assay

173

418

2.86

32.56

2.7

2.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

8.34

32.55

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

510

1953

1.82

32.33

1.5

1.3

11.83

9.71

u/l

2.53

411

1564

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

226

633

2.47

32.04

1.2

1.1

2.86

3.05

0.11

161

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

298

949

2.18

31.63

1.3

1.2

279.22

244.97

u/ml

0.93

205

654

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

312

1016

2.13

31.34

1.3

1.2

44.02

47.56

u/ml

0.10

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

248

733

2.35

31.32

1.6

1.7

404.92

421.33

mu/l

0.12

198

575

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

108

198

3.76

31.19

1.3

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

129

268

3.32

31.12

1.2

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

213

590

2.50

30.91

1.2

0.76

1.26

0.58

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

126

260

3.34

30.72

1.0

302.00

294.10

mg/l

0.43

115

244

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

108

201

3.70

30.56

2.0

1.6

14.28

13.72

0.22

103

195

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

291

934

2.16

30.31

1.5

1.3

152.86

149.76

au/ml

0.16

270

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

11.86

30.17

1.1

1.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

169

3.95

29.99

1.2

1.3

22.44

24.97

u/l

0.15

142

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

197

535

2.55

29.78

1.1

1.48

1.46

g/l

0.15

183

498

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

302

993

2.11

29.61

1.4

1.3

16.73

21.10

u/ml

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

501

1969

1.78

29.16

1.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

176

3.83

29.12

1.2

1.3

81.47

101.22

u/l

0.82

155

(3008295) Osmolality of Serum or Plasma

127

273

3.21

29.09

1.5

284.34

278.38

mosm/kgh2o

1.61

222

(3016650) Hepatitis A virus Ab [Presence] in Serum

248

758

2.27

29.06

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

117

242

3.33

28.46

3.6

3.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

133

299

3.07

28.36

1.2

0.37

3.16

u/ml

3.16

165

(3047007) Chlamydophila sp Ab [Presence] in Serum

237

718

2.29

28.35

1.3

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

302

1017

2.06

27.85

1.5

1.3

27.71

26.83

u/l

0.15

242

848

(3026250) Tacrolimus [Mass/volume] in Blood

5.06

27.74

45.3

33.9

7.38

7.22

ug/l

0.23

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

183

3.69

27.65

2.4

2.2

525.40

522.15

e6/l

0.02

144

(3021387) Prolactin [Units/volume] in Serum or Plasma

685

2976

1.61

27.52

1.7

1.6

298.74

318.74

mu/l

0.62

612

2655

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

109

220

3.41

27.52

1.3

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

109

220

3.41

27.52

1.3

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

109

220

3.41

27.52

1.3

1.5

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

124

274

3.12

27.21

14.8

13.1

0.64

0.62

mmol/l

0.54

114

252

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

4.95

27.11

1.7

2.6

109.97

143.60

umol/l

0.34

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

101

196

3.55

27.00

2.5

2.3

232.89

232.55

e6/l

0.01

159

(3022493) Free Hemoglobin [Mass/volume] in Plasma

131

4.20

26.79

21.4

3.9

1764.89

3271.60

mg/l

0.23

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

150

375

2.76

26.63

1.2

1.5

—

titre

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

173

3.70

26.39

1.5

1.6

5.67

5.78

u/l

0.03

140

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

11.92

26.27

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

10.44

25.87

1.2

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

10.44

25.87

1.2

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

10.44

25.87

1.2

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

10.44

25.87

1.2

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

149

3.88

25.43

1.3

163.64

164.03

mmol/24h

0.01

149

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

5.64

25.42

1.0

35.23

28.72

ng/l

0.69

(3035320) C reactive protein [Mass/volume] in Body fluid

127

298

2.94

25.25

2.8

2.2

21.41

28.68

mg/l

1.60

200

(1761482) Bacteria [#/volume] in Urine by Culture

236

752

2.17

25.09

4.0

2.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

202

603

2.32

25.04

1.3

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

117

264

3.05

24.86

3.6

3.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

227

720

2.18

24.42

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

142

3.88

24.21

2.6

1.7

16.19

51.17

mg/l

1.08

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

5.46

24.18

1.0

676.34

873.96

ng/l

1.70

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

185

3.46

24.04

1.4

1.1

—

(3042733) HLA Ab [Presence] in Serum

5.52

24.00

5.3

3.8

—

(3003694) ABO and Rh group [Type] in Blood

3457

20137

1.25

23.92

1.6

1.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

138

350

2.72

23.90

1.2

1.1

110.01

125.70

pmol/l

2.24

138

350

(3023511) Choriogonadotropin [Units/volume] in Urine

427

1699

1.75

23.84

1.4

1.3

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

160

3.66

23.77

1.8

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

108

4.33

23.67

1.5

1.4

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

5.43

23.65

1.0

262.63

268.74

ng/l

0.05

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

227

730

2.15

23.62

1.1

—

(3033099) Centromere Ab [Titer] in Serum

7.03

23.61

1.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

383

1481

1.80

23.55

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

722

3292

1.54

23.52

2.9

4.0

37.65

54.96

u/ml

1.54

695

3228

(3006922) Hepatitis E virus Ab [Presence] in Serum

128

315

2.80

23.44

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

11.43

23.35

1.1

—

(3017354) Segmented neutrophils/Leukocytes in Blood

121

290

2.88

23.23

3.2

3.8

57.44

54.41

0.72

107

246

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

112

258

2.99

23.02

1.9

2.4

98.51

95.97

0.26

105

238

(3051611) Lipemic interference index of Serum or Plasma

132

334

2.72

22.98

4.2

2.9

15.07

12.77

index

1.00

215

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

5.98

22.97

1.1

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

6.43

22.95

1.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

171

494

2.39

22.83

1.6

1.9

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

5.78

22.76

1.3

1.1

11.73

8.94

pmol/l

0.32

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

260

894

2.01

22.74

1.2

1.1

14.28

13.61

au/ml

0.05

327

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

112

4.17

22.66

1.5

1.4

—

(4034850) Laboratory test

331

1240

1.85

22.54

12.5

5.8

—

(3016038) Potassium [Moles/volume] in Urine

151

3.64

22.31

1.2

34.65

38.82

mmol/l

0.68

136

(3000012) Reticulocyte production index

138

366

2.60

21.98

2.0

2.3

0.88

0.86

0.20

231

(3014271) Vancomycin [Susceptibility]

5.66

21.85

2.9

2.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

5.10

21.79

2.2

2.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

101

4.29

21.71

1.4

1.5

85.40

282.51

nmol/24h

0.53

101

(3017569) Oxygen content in Arterial blood

4.58

21.61

2.2

2.3

15.88

15.83

0.03

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

+∞

21.48

1.7

0.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

819

3906

1.47

21.47

2.4

2.2

5949.91

6339.24

u/l

0.13

335

1847

(4094501) Cardiovascular stress test using bicycle ergometer

305

1135

1.86

21.23

1.1

—

(3006245) CD3-CD19+ cells/cells in Blood

122

3.89

21.04

2.0

1.7

10.34

13.56

1.09

115

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

148

3.58

20.96

1.1

9.25

12.57

u/ml

—

(40768446) Kidney Pathology biopsy report

5.54

20.96

1.7

1.8

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

126

3.82

20.85

2.0

1.7

28.35

26.78

0.37

121

(3003434) Protein [Mass/volume] in Pleural fluid

156

451

2.39

20.83

1.6

1.3

33.20

35.55

g/l

1.31

138

414

(3010375) cycloSPORINE [Mass/volume] in Blood

4.25

20.49

29.5

26.2

113.79

135.32

ug/l

1.38

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

144

405

2.45

20.40

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

161

478

2.32

20.29

2.5

3.7

3.89

4.59

nmol/l

0.39

150

462

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

109

267

2.81

20.19

1.0

1.1

—

0.47

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

176

3.28

20.16

1.6

1.4

28.07

21.48

u/ml

0.38

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

874

8192

0.71

20.14

1.6

928.92

1066.02

mu/l

4.26

712

6981

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

10.29

19.78

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

182

3.21

19.74

1.3

1.4

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

233

2.92

19.69

1.4

1.3

28.95

27.32

umol/l

0.16

217

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

9.04

19.60

1.1

1.0

—

(3011436) Histone Ab [Units/volume] in Serum

8.18

19.56

1.1

1.0

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

5.39

19.54

1.2

1.1

113.49

109.98

nmol/l

0.05

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

4.32

19.54

1.8

1.5

2437.71

3388.89

u/ml

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

132

366

2.49

19.29

1.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

143

414

2.38

19.08

1.6

1.3

2021.32

3376.20

e6/l

0.38

284

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

103

253

2.80

19.01

1.2

1.3

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.74

19.01

1.2

1.3

97.98

92.18

0.52

(4035726) Immunohistochemistry procedure

928

4633

1.40

18.95

1.4

—

(3042631) Mycobacterium sp identified in Specimen

121

326

2.56

18.76

2.2

2.7

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

10.71

18.75

1.5

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

344

1381

1.73

18.68

1.7

1.6

49.32

48.18

nmol/l

0.22

336

1364

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

101

248

2.80

18.66

1.2

1.3

—

(21494815) CD4 cells/Lymphocytes in Specimen

111

288

2.65

18.52

2.2

2.0

40.50

36.64

1.75

106

283

(3019420) Tryptase [Mass/volume] in Serum or Plasma

219

2.92

18.50

1.7

11.54

7.61

ug/l

0.41

200

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

239

2.82

18.34

1.1

1.08

1.06

ratio

0.56

199

(3000060) B lymphocytes [#/volume] in Blood

4.28

18.31

1.9

1.7

0.22

0.78

e9/l

0.57

(21494755) Public health laboratory ask at order entry panel

1054

9444

0.74

18.14

1.3

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

150

3.35

18.09

1.3

1.2

55.00

106.92

titre

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

8.82

17.95

1.1

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

8.82

17.95

1.2

1.3

—

(3006270) Folate [Moles/volume] in Blood

246

2.77

17.92

1.1

379.87

407.62

nmol/l

0.64

234

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

8.00

17.40

1.1

1.2

2.22

2.23

iu/ml

0.00

(3044242) Glucose [Moles/volume] in Arterial blood

101

3.88

17.40

1.9

1.7

10.09

6.98

mmol/l

2.18

101

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

6.65

17.23

1.2

1.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

4.24

17.09

1.6

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

4.24

17.09

1.6

1.4

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

156

3.22

17.06

1.3

1.2

1130.00

866.25

titre

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

972

4978

1.37

16.98

3.5

5.4

26.69

43.87

ug/l

0.41

752

3892

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

9.68

16.94

1.3

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

116

328

2.43

16.35

1.2

81.97

81.20

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2164

12392

1.24

16.26

5.8

5.3

2.66

3.86

ug/l

1.47

1922

11415

(3020191) Ethanol [Moles/volume] in Serum or Plasma

194

2.87

15.72

1.5

1.2

1.33

1.50

promille

0.40

157

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.93

15.61

1.1

1.0

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

121

358

2.33

15.48

1.5

1.2

4.75

6.16

umol/l

4.04

113

323

(3045788) Cell count panel - Pleural fluid

120

354

2.33

15.46

1.6

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

239

2.65

15.40

2.3

2.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

116

341

2.34

15.07

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

771

3880

1.39

14.97

2.4

1.9

11.53

12.75

nmol/l

3.09

695

3593

(3047352) Trisomy 18 risk [Likelihood] in Fetus

367

3840

0.64

14.93

1.5

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

104

292

2.45

14.92

1.4

1.2

387.32

668.70

u/l

1.08

284

(37208534) Antinuclear antibody arbitrary concentration in serum

118

3.38

14.66

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

378

3907

0.65

14.51

1.5

1.6

—

(3028707) Methadone [Presence] in Urine by Screen method

260

1039

1.73

14.44

2.3

2.0

—

(3005033) Fetal Nuchal fold Thickness US

363

3772

0.65

14.29

1.4

1.5

1.24

1.26

0.42

251

2827

(21494814) CD8 cells/Lymphocytes in Specimen

3.84

14.24

2.0

1.6

26.51

32.29

1.60

(3010370) Gastrin [Moles/volume] in Serum or Plasma

4.75

14.08

2.1

2.0

38.89

26.83

pmol/l

0.58

(3036782) Glucose [Moles/volume] in Pleural fluid

119

365

2.24

14.07

1.5

1.2

6.48

5.43

mmol/l

4.66

104

341

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

4.62

14.02

1.7

1.9

40.90

41.12

g/l

0.07

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

4.62

14.02

1.1

1.4

330.22

303.49

pmol/l

0.11

(3034426) Prothrombin time (PT)

108

3.43

14.01

1.3

29.09

27.41

1.12

108

(3004716) Salmonella sp identified in Stool by Organism specific culture

621

3045

1.42

14.01

1.4

1.5

—

(3012441) Differential panel - Pleural fluid

116

354

2.26

13.88

1.5

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2351

13775

1.21

13.86

1.8

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1260

10666

0.78

13.85

1.9

1.8

3.44

3.33

ratio

2.51

949

7843

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

14.28

13.78

8.4

8.9

5.10

5.37

mmol/l

0.18

(3036670) Protein [Mass/volume] in Synovial fluid

14.28

13.78

1.4

1.0

41.36

35.44

g/l

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

141

3.07

13.76

1.2

1.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

3.62

13.71

1.4

1.1

86.83

80.00

0.40

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

153

2.96

13.60

1.2

106.05

109.85

0.23

142

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

242

965

1.73

13.57

1.1

2.79

2.82

eliau/ml

0.01

115

575

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

146

3.01

13.55

1.2

0.30

0.28

g/l

0.88

117

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

176

2.81

13.54

1.2

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

119

373

2.20

13.39

1.5

1.4

24594.05

32394.07

e6/l

0.40

220

(40768806) Pleura Pathology biopsy report

117

365

2.21

13.32

1.7

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

112

3.31

13.30

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

4.62

13.28

1.3

1.6

78.80

62.79

mu/l

0.17

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

107

323

2.28

13.16

1.1

1.0

—

(3020491) Glucose [Moles/volume] in Blood

105

315

2.29

13.10

1.8

1.5

6.50

5.38

mmol/l

5.59

252

(3024869) Neuronal Ab [Presence] in Serum

12.24

12.99

1.2

1.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

143

2.98

12.91

1.1

82.93

97.83

1.15

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

16.75

12.89

2.0

1.7

—

(3035880) pH of Pleural fluid

167

2.80

12.70

1.3

1.2

7.42

7.41

0.13

112

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

269

2.38

12.60

1.3

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

3.43

12.49

1.3

1.1

81.80

70.19

0.62

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

100

3.36

12.39

1.2

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.87

12.27

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

155

2.84

12.27

1.3

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

155

2.84

12.27

1.3

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

155

2.84

12.27

1.3

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

155

2.84

12.27

1.3

1.7

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.64

12.19

1.6

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

5.57

12.00

1.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

142

2.90

11.99

1.2

112.17

107.23

0.62

132

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

226

920

1.70

11.83

2.0

1.6

185.46

198.09

pmol/l

0.90

203

885

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

132

2.96

11.82

1.2

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

3.82

11.81

1.1

1.2

—

u/ml

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

136

2.93

11.78

1.2

1.4

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

963

8269

0.78

11.77

1.7

1.6

3.50

3.49

mmol/l

0.09

669

5407

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

221

2454

0.61

11.72

1.3

—

(3028717) Thiamine [Mass/volume] in Blood

5.88

11.64

1.2

1.4

62.00

75.96

ug/l

1.15

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

6.85

11.62

1.0

1.1

0.76

0.69

iu/ml

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

255

2.34

11.49

1.4

1.1

11.30

8.49

mm/h

1.10

255

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

377

3722

0.68

11.49

1.1

0.59

0.61

ratio

0.16

386

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

6.06

11.48

2.0

1.5

7.33

5.67

mmol/l

1.35

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

398

3886

0.69

11.42

1.6

1.7

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

235

2.40

11.37

1.4

1.2

11.92

12.88

u/l

0.30

222

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

502

4702

0.72

11.30

1.5

62.50

64.00

ug/l

0.27

411

3924

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

10.51

11.24

1.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

477

4501

0.71

11.23

1.4

1.5

0.94

0.95

ratio

0.25

280

2746

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

477

4501

0.71

11.23

1.4

1.5

1.14

1.19

ratio

0.59

284

2761

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

476

4486

0.71

11.13

1.4

1.5

1.12

1.19

ratio

0.98

279

2731

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

149

2.76

11.04

1.2

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

150

2.75

10.91

1.1

85.41

95.41

0.98

(3028433) Virus identified in Specimen by Culture

3.28

10.77

1.0

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.68

10.67

4.1

1.7

5.06

4.63

kpa

1.79

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.68

10.67

4.1

1.7

10.29

10.97

kpa

0.71

(3050129) First trimester maternal screen panel - Serum or Plasma

585

5304

0.74

10.67

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

473

4425

0.72

10.57

1.4

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

101

3.13

10.45

2.7

2.6

0.61

0.62

mmol/l

0.36

101

(44806420) Estimation of glomerular filtration rate

163

631

1.78

10.23

2.3

1.7

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

213

2.39

10.22

2.4

2.6

41.69

38.00

0.84

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

11.42

10.21

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

164

2.60

10.17

1.6

6432.00

1993.85

titre

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

109

370

2.03

10.14

1.1

12.75

7.13

iu/ml

0.99

153

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

293

2956

0.67

10.03

1.5

62.76

62.22

ug/l

0.07

293

2956

(3016244) Insulin [Units/volume] in Serum or Plasma

259

2.23

9.95

3.3

3.1

24.23

22.05

mu/l

0.25

244

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

308

1412

1.51

9.92

1.3

1.4

100.97

130.38

pmol/l

0.63

299

1384

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.85

9.83

1.3

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

108

371

2.00

9.74

1.2

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

102

344

2.04

9.67

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.63

9.58

1.3

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

10.85

9.52

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

151

587

1.77

9.39

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

3.22

9.34

1.1

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

100

342

2.01

9.16

1.2

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

104

2.90

8.90

1.7

2.7

8.27

10.36

mg/l

1.34

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

13.70

8.89

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

3.48

8.87

1.8

1.5

9.62

9.67

ug/l

0.01

(3047189) Immunofixation for 24 hour Urine

3.11

8.85

1.9

2.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

217

946

1.58

8.80

4.4

2.4

24.14

28.21

mg/l

1.03

139

625

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

4.28

8.79

7.6

10.9

75.10

78.52

0.28

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

5.42

8.58

1.3

1.0

0.05

1.22

u/ml

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

5.42

8.58

1.5

1.06

4.00

mg/l

1.01

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

5.42

8.58

1.5

2.67

0.95

mg/l

0.88

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

5.42

8.58

1.5

0.81

3.10

mg/l

0.76

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

5.42

8.58

1.5

1.52

1.33

mg/l

0.08

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

5.42

8.58

1.5

2.03

3.00

mg/l

0.24

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

5.42

8.58

1.5

0.41

0.67

mg/l

0.31

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

5.42

8.58

1.5

0.84

0.63

mg/l

0.13

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

5.42

8.58

1.5

2.09

4.32

mg/l

0.65

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

3.94

8.57

1.5

1.1

0.93

272.29

mg/l

1.28

(21494434) Karyotype in Bone marrow

258

2.13

8.56

1.1

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

2673

16394

1.15

8.52

2.0

2.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

159

2.46

8.48

2.0

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1720

10216

1.18

8.27

4.5

4.1

22.49

21.31

2.12

812

5090

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

3.49

8.10

2.3

2.2

20.05

84.07

u/l

0.88

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.87

8.10

1.1

1.0

0.53

0.63

umol/24h

0.55

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

17.81

7.97

1.1

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

17.81

7.97

1.1

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

5.01

7.93

1.0

1.1

—

(4015189) Microbial culture of sputum

3.43

7.92

2.5

1.8

—

(3024932) HLA-DR beta [Type]

2.93

7.85

1.0

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

3.49

7.85

1.3

1.1

1.59

2.01

mmol/l

0.70

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

116

2.66

7.84

1.4

1.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

263

2.06

7.84

1.3

—

(3024471) HLA-A [Type]

2.88

7.82

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

7.23

7.76

1.0

0.02

0.04

u/ml

0.51

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

3.11

7.75

1.4

1.9

124.62

103.67

au/ml

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

181

2.28

7.58

1.0

1.1

91.24

90.07

0.13

131

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

319

1557

1.41

7.54

1.1

2.35

2.47

u/ml

0.07

166

836

(3045142) Bone marrow Pathology biopsy report

105

392

1.84

7.54

1.2

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

107

2.69

7.50

3.8

2.3

1.06

1.49

0.80

107

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

513

2706

1.31

7.41

2.0

1.7

—

(1761868) Lipid panel - Serum or Plasma

4304

27411

1.12

7.38

3.2

2.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

116

2.60

7.37

1.4

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

116

2.60

7.37

1.4

1.9

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

513

2708

1.31

7.37

1.4

1.3

228.79

230.19

miu/ml

0.03

251

1410

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.37

7.23

1.2

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

283

1368

1.43

7.08

1.1

3.87

5.57

u/ml

1.51

157

757

(3027231) Wheat IgE Ab [Units/volume] in Serum

115

2.56

7.02

1.0

1.1

0.32

2.71

u/ml

0.59

105

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

117

462

1.74

7.02

1.2

1.1

18.64

15.53

u/ml

0.54

221

(44806071) Cardiolipin IgM antibody measurement

3.57

7.01

1.0

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1569

12236

0.86

6.96

1.8

—

(40768441) Liver Pathology biopsy report

342

1.85

6.74

1.3

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

189

854

1.52

6.66

3.2

4.5

496.37

1374.76

u/ml

0.77

168

783

(3008401) Mugwort IgE Ab [Units/volume] in Serum

272

1322

1.42

6.64

1.1

0.53

1.23

u/ml

2.40

118

606

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2245

13812

1.14

6.62

1.6

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

123

2.45

6.60

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

310

1545

1.38

6.55

1.5

0.41

0.48

nmol/l

1.02

243

1248

(3005532) Lymphocytes/Leukocytes in Pleural fluid

2.73

6.45

1.7

1.3

62.62

60.87

0.09

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

164

2.22

6.38

2.1

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

164

2.22

6.38

2.1

1.6

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

+∞

6.26

1.1

0.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.18

6.20

2.5

1.8

19.72

13.27

umol/l

1.55

(3020874) Milk IgE Ab [Units/volume] in Serum

116

477

1.67

6.08

1.0

1.1

0.55

2.42

u/ml

1.27

129

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

280

1.89

6.07

2.4

1.7

1.78

1.54

u/field

0.23

142

(3042517) Benzodiazepines panel - Urine

4.31

6.07

2.8

3.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

10.27

6.07

3.3

1.3

0.63

0.60

ug/l

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

203

954

1.46

5.97

1.2

1.1

—

(3006462) Nitrate [Presence] in Urine

192

2.07

5.94

2.8

2.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

5.55

5.91

1.8

1.6

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.83

5.88

1.6

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

4.16

5.82

1.2

1.3

112.94

80.00

titre

0.74

(44813793) Dust mix specific IgE antibody measurement

306

1.82

5.71

1.1

1.0

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

6.85

5.69

2.4

2.6

1.97

0.68

mmol/l

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

107

442

1.66

5.55

1.3

1.5

—

(4211845) Urine protein measurement

217

1.96

5.50

2.6

2.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

271

1363

1.37

5.48

1.1

2.69

1.95

u/ml

0.47

134

700

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

8.22

5.47

1.2

1.1

—

(3022725) Serotonin [Moles/volume] in Serum

6.39

5.46

2.3

1.1

838.21

1835.33

nmol/l

0.50

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

135

2.23

5.45

2.2

3.0

141.64

160.65

au/ml

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.95

5.34

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.06

5.33

1.2

1.1

—

(3002619) Bacteria identified in Specimen by Culture

2.45

5.30

1.1

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

229

1127

1.40

5.29

1.9

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

466

2542

1.27

5.29

1.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.52

5.28

2.4

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

343

1799

1.31

5.27

3.1

4.5

238.41

1649.34

u/ml

2.56

294

1574

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

2.74

5.26

1.1

1.0

78.57

87.93

ug/l

0.36

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.76

5.15

1.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

6.36

5.09

1.1

1.0

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

3.08

5.03

1.2

22.24

24.44

0.11

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

6.85

4.95

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

281

1447

1.34

4.93

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.13

4.93

1.8

1.5

1.19

mmol/l

0.06

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.92

4.84

1.0

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

7.53

4.83

1.1

1.0

29.73

9.20

u/l

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.64

4.78

1.1

1.3

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

3.06

4.77

1.4

1.0

1.38

0.86

mmol/l

0.25

(3002523) Influenza virus A Ag [Presence] in Specimen

280

1450

1.33

4.74

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

181

1.97

4.74

1.1

1.0

6.68

16.27

u/ml

—

(3043410) Blood group antigens tested for on Red Blood Cells

108

2.28

4.74

2.2

1.6

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

6.32

4.72

1.0

1.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

5.56

4.67

1.4

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

3.33

4.65

1.8

1.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

494

2764

1.23

4.53

2.4

1.5

4.67

3.18

mg/l

2.20

400

1726

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

106

2.26

4.52

1.3

1.4

0.23

0.35

nmol/l

0.72

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1320

8031

1.14

4.52

3.3

3.1

0.74

0.86

ug/l

3.71

895

4936

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

3.54

4.49

1.3

1.1

24.00

46.52

u/l

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

389

1.62

4.45

1.7

1.6

—

(4198724) Urine methamphetamine measurement

200

1.89

4.45

1.9

1.7

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

108

2.22

4.35

1.2

1.6

4.67

6.40

nmol/l

1.86

103

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

257

1.76

4.32

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

10.95

4.31

1.0

0.03

0.06

u/ml

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

2.47

4.21

1.7

1.3

4.20

2.81

0.21

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.69

4.17

1.4

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

200

1.85

4.16

2.5

1.4

1.08

4.96

u/field

0.95

137

(3019768) Coxiella burnetii Ab [Presence] in Serum

5.79

4.14

1.2

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.77

4.07

1.3

2.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.44

3.98

1.1

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

6.22

3.98

2.0

1.4

524.55

166.19

nmol/l

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.37

3.91

1.3

1.2

22.22

334.93

ug/l

1.35

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

158

773

1.40

3.89

1.2

1.3

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

3.31

3.87

5.3

3.8

31.56

34.60

ug/min

—

(3019174) dRVVT (LA screen)

4.24

3.80

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

104

474

1.51

3.71

1.0

1.1

5.52

3.28

u/ml

0.17

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

117

2.05

3.63

4.0

3.7

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

4.33

3.61

1.0

0.15

1.08

u/ml

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

166

1.86

3.56

3.0

4.0

7.88

9.36

mg/l

0.81

141

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.11

3.54

1.3

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

229

1210

1.30

3.48

1.1

2.89

3.35

u/ml

0.22

105

610

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

2.84

3.47

1.9

1.2

18.00

0.00

(3034274) Bile acid [Moles/volume] in Serum --fasting

287

1563

1.26

3.44

2.1

2.4

5.26

5.95

umol/l

0.54

204

1135

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

166

844

1.35

3.31

2.5

2.7

44.21

23.95

iu/ml

0.64

(40761995) Spermatozoa Progressive [#/volume] in Semen

142

0.29

3.31

2.5

3.5

31.00

47.24

—

142

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

142

0.29

3.31

5.0

7.0

7.17

8.56

—

142

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

534

3113

1.18

3.29

1.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

151

1.86

3.28

1.0

1.1

3.13

7.48

u/ml

0.35

(3001964) Herpes simplex virus Ag [Presence] in Specimen

113

2.00

3.25

1.9

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

6.09

3.24

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

125

609

1.41

3.23

1.6

—

(40762887) Creatinine [Moles/volume] in Blood

5.13

3.21

1.8

1.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.18

2.5

1.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.74

3.18

1.2

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

193

1011

1.31

3.16

1.0

1.1

0.15

0.42

u/ml

1.20

279

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.84

3.08

1.3

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

3.57

3.05

3.2

8.6

—

(40757373) Influenza virus identified in Isolate

2.40

3.03

1.9

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

102

2.02

3.03

1.1

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

8.21

2.95

2.3

1.0

1.86

2.59

mu/l

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

180

948

1.30

2.87

1.2

1.3

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

5.99

2.86

1.3

1.5

30.57

46.12

umol/24h

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.59

2.85

1.1

1.0

—

(3022475) Manganese [Moles/volume] in Blood

2.70

2.85

1.2

1.3

0.16

0.15

umol/l

0.14

(4212803) Bone marrow aspirate examination

3.80

2.78

1.0

—

(40768800) Prostate Pathology biopsy report

121

1119

0.74

2.77

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

213

1154

1.27

2.74

1.1

5.44

4.52

u/ml

0.13

530

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.13

2.69

1.3

1.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

4.56

2.68

2.9

3.6

100.00

106.33

g/l

—

(3051101) Glucose [Moles/volume] in Cord blood

4.56

2.68

6.3

1.4

8.39

6.32

mmol/l

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

5.32

2.66

1.1

1.8

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

130

1180

0.75

2.64

1.5

—

(3014891) Appearance of Pleural fluid

2.57

2.61

2.2

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1574

9980

1.09

2.57

2.1

2.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

186

1.66

2.53

5.5

10.5

2638.00

11194.84

u/ml

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.14

2.50

1.2

1.0

1.36

1.29

umol/24h

0.13

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

208

1.61

2.49

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

263

1.54

2.45

1.2

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

204

1.61

2.44

1.1

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

238

1328

1.23

2.42

1.6

1.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

3.01

2.39

1.5

1.2

437.36

344.20

umol/24h

0.52

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.01

2.39

1.3

—

(3001729) Color of Synovial fluid

6.84

2.31

1.4

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.39

2.29

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.89

2.28

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

106

1.81

2.16

1.1

1.2

—

1571.43

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.42

2.11

2.9

1.6

51.50

44.13

umol/l

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

117

1.76

2.11

1.2

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

5.70

2.10

1.2

—

(3011288) Drugs identified in Urine by Screen method Nominal

380

2247

1.16

2.09

2.9

1.8

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

198

1.56

2.03

1.0

6.42

11.57

u/ml

1.27

137

(40768793) Breast Pathology biopsy report

299

1741

1.18

2.00

1.3

—

(3026726) Creatinine [Moles/volume] in Specimen

2.60

1.98

2.4

1.1

416.82

970.21

umol/l

0.47

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

4.11

1.96

1.2

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

4.89

1.91

1.0

1.1

29.26

39.30

mg/24h

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.42

1.90

1.0

2.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.51

1.87

2.7

3.8

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.90

1.82

2.1

3.0

10.30

1061.38

ug/l

0.51

(3025130) Human papilloma virus identified in Specimen

276

1613

1.18

1.80

1.8

1.9

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.88

1.76

4.7

6.2

5.60

5.19

kpa

0.28

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

4.28

1.75

4.2

6.4

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

455

1.33

1.73

1.0

1.1

0.18

1.21

u/ml

0.68

(3032868) Hemoglobin electrophoresis panel in Blood

1.97

1.72

1.9

1.6

—

(40768795) Lymph node Pathology biopsy report

104

553

1.29

1.69

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

507

1.30

1.65

1.2

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.44

1.62

1.1

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.12

1.58

2.7

1.7

0.77

0.64

u/field

0.12

(1001926) Buprenorphine [Presence] in Urine by Screen method

426

2599

1.13

1.56

1.9

1.5

—

(3009677) Dengue virus Ab [Presence] in Serum

2.57

1.52

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

2.57

1.52

1.1

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

2.21

1.48

1.3

1.8

—

(3018001) Oat IgE Ab [Units/volume] in Serum

2.21

1.48

1.0

0.07

0.14

u/ml

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

1.89

1.46

1.1

1.0

0.09

0.51

u/ml

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

127

1062

0.82

1.46

1.7

7.69

7.37

mmol/l

0.92

122

1022

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1714

11146

1.06

1.46

2.2

2.1

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

1.79

1.40

1.9

1.3

17.66

20.80

0.18

(3001556) Androgen free Index in Serum or Plasma

1.79

1.40

1.6

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

329

1.33

1.37

1.8

1.9

1.01

1.94

u/ml

1.10

108

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.71

1.37

1.0

1.1

19.43

6.24

u/ml

0.67

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

134

1.53

1.35

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

134

1.53

1.35

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

134

1.53

1.35

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.49

1.33

1.4

3.5

—

(3050794) Legionella sp Ab [Presence] in Serum

2.49

1.33

1.3

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.57

1.28

1.0

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

1.67

1.27

1.2

1.0

0.01

0.03

u/ml

0.79

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.85

1.25

1.0

1.2

222.00

208.17

nmol/l

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

2.85

1.25

1.0

1.5

1.28

1.39

—

(3046861) Legionella sp Ag [Presence] in Urine

2.85

1.25

1.0

—

(3016879) Cocaine [Presence] in Urine

507

3171

1.10

1.24

1.8

1.5

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

2.19

1.20

3.6

4.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

311

0.70

1.17

1.2

60.97

69.51

ug/l

0.51

311

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.40

1.13

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.28

1.10

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

2.05

1.07

1.0

1.4

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

2.18

1.06

1.1

1.0

8.63

8.64

mmol/l

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

124

0.55

1.06

1.0

1.1

1.18

1.28

mom

—

124

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.78

1.04

1.3

1.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

214

1.34

1.02

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

1.00

0.0

1.1

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

1.90

0.97

1.1

1.0

3.91

9.60

u/ml

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

102

829

0.84

0.96

1.4

30.66

37.41

nmol/l

1.49

780

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

157

935

1.15

0.94

1.4

1.5

6.56

6.23

mmol/l

0.96

142

834

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

333

1.25

0.92

1.7

2.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

1.53

0.91

1.4

1.1

17.61

13.17

g/l

1.45

(3044007) Cell count panel - Peritoneal fluid

138

1.39

0.85

1.8

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.62

0.85

3.5

3.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.47

0.84

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.96

0.84

1.2

1.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.71

0.80

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.62

0.79

1.2

1.6

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

257

1929

0.91

0.78

1.3

2.91

3.49

ug/l

0.52

229

1798

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.92

0.75

2.7

2.2

258.57

205.90

ug/l

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1130

7418

1.05

0.75

2.2

2.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.77

0.72

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.47

0.72

2.9

2.8

—

(3000764) Benzodiazepines [Presence] in Urine

543

3501

1.06

0.71

1.8

1.5

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

1.90

0.69

1.0

—

0.12

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.90

0.69

1.0

1.2

—

(3027008) Opiates [Presence] in Urine

544

3516

1.06

0.67

1.8

1.5

—

(3028300) Cannabinoids [Presence] in Urine

545

3527

1.06

0.65

1.8

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

141

1.31

0.62

1.0

22.22

34.27

iu/ml

0.80

141

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

137

0.70

0.61

2.7

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

384

1.18

0.60

1.1

1.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.79

0.59

1.7

1.5

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.56

0.57

1.0

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

338

1.18

0.54

1.4

1.2

159.40

186.56

pmol/l

0.85

338

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

1.52

0.52

3.3

1.3

16.27

41.93

nmol/l

—

(3027944) Amphetamines [Presence] in Urine

537

3504

1.05

0.51

1.8

1.5

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

158

1.26

0.51

1.8

1.5

851.79

1140.47

e6/l

0.34

(3041806) Other cells [#/volume] in Blood by Manual count

386

0.85

0.49

1.6

1.3

0.54

0.50

e9/l

0.61

386

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

130

1.26

0.46

2.0

2.3

1.25

3.93

ug/l

0.82

(3010937) Rubella virus Ab [Presence] in Serum

1.42

0.45

1.2

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

384

1.14

0.44

1.3

1.4

1220.00

1019.54

titre

0.44

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

905

6002

1.03

0.43

2.0

1.9

—

(40765089) Chromosome analysis panel - Blood by G-banded

329

0.85

0.43

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.0

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

1.49

0.41

1.2

1.6

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

356

0.86

0.40

21.4

14.6

834.58

862.61

nmol/l

0.14

343

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

139

1.23

0.40

1.5

1.4

5496.77

5747.34

e6/l

0.03

(3020650) Glucose [Presence] in Urine

215

1.18

0.39

1.4

1.3

0.00

estimate

-0.00

215

(40765096) Chromosome analysis panel by Banding

102

0.74

0.39

1.1

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.37

0.38

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

437

1.08

0.23

1.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.22

0.22

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.22

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.22

0.0

1.0

—

(3017509) Phencyclidine [Presence] in Urine

1.20

0.19

1.6

1.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.16

0.17

1.4

1.5

5.52

5.39

mmol/l

0.25

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

338

0.93

0.15

1.2

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

115

1.13

0.15

1.1

3.38

3.90

u/ml

0.05

(4133840) Spirometry

139

0.89

0.15

1.3

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

150

1.09

0.12

3.0

3.1

68.05

97.02

ng/l

—

(3029396) Erythrocyte agglutination [Presence] in Blood

425

1.05

0.11

2.8

3.5

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

1.14

0.08

1.1

1.0

0.08

0.40

u/ml

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.12

0.06

6.5

6.7

12.02

10.74

—

(40758292) HTLV I+II Ab panel - Serum

0.92

0.06

1.1

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

536

0.98

0.03

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

105

725

0.99

0.01

1.6

240.78

446.38

pmol/l

0.34

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.94

0.01

1.1

—

(4281824) Cell count and differential, peritoneal fluid

114

783

1.00

0.00

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.90

-0.00

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.90

-0.00

1.0

0.07

0.21

u/ml

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: THYROID_DISORDER_IBD – Disorders of thyroid, IBD co-morbidities

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Disorders of thyroid, IBD co-morbidities

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints